IG:HL7 diagnosis: Unterschied zwischen den Versionen

Aus Hl7wiki
Wechseln zu: Navigation, Suche
(6 - 6.2)
(→‎Ann Arbor Codes)
 
(200 dazwischenliegende Versionen von 4 Benutzern werden nicht angezeigt)
Zeile 1: Zeile 1:
−
Representation of Diagnosis based on the Clinical Document Architecture Rel.2 for Healthcare in Germany
+
{{Underconstruction}}
 +
{{NoteBox|Representation of Diagnosis based on the Clinical Document Architecture Rel.2 for Healthcare in Germany
 +
 
 +
Version 1.1}}
 +
 
  
−
Version 1.1
 
  
 
==Introduction==
 
==Introduction==
 
===Introduction===
 
===Introduction===
 +
 +
Documentation of diagnoses is an essential part of many workflows in healthcare systems.
 +
 +
The ways of documenting a diagnosis may depend on the purpose such as medical, statistical,
 +
research-related, legal or administrative purposes.
 +
 +
This guideline focusses on the structured electronic documentation of diagnoses for the following applications:
 +
 +
====[[Bild:Flag_de.svg|border|27px]] Germany====
 +
 +
Fields of application for diagnosis documentation in Germany are e.g.
 +
* Capturing a diagnosis for the purpose of billing an  ICD-10-GM code under Federal German Code SGB V
 +
** under law §301 for in-patients
 +
** under law §295 for out-patients /ambulatory care
 +
** under law §140 for integrated care plans ("IGV-MVZ")
 +
* Cause-of-death statistics based on ICD-10 WHO
 +
* Quality assurance as of law §137 SGB V and related hospital quality reports
 +
* Infectious disease reporting as required under Infektionsschutz-Gesetz
 +
* Epidemiology and cancer registers (using ICD-O), including further classification of tumor diseases (1)
 +
* Expertise by payor for the purpose of retirement plans and statutory insurances (using e.g. ICF)
 +
* Medical documentation in healthcare such as referral letters, admission letters, sick-leave-notes, prescriptions, in-patient EHRs
 +
* Clinical studies (MedDRA, WHO-Art)
 +
* Payor Risk Compensation as of "Risikostrukturausgleich" ruling
 +
* Product detail information for medication, such as indications, counter-indications amd sideeffects ("UAW")
 +
 +
Administrative documentation of diagnoses will be required for justifying the billing of therapy such as treatment/procedures.
 +
 +
Since Jan 1st 2000 the classification ICD-10 GM as mandatory for diagnosis encoding in both ambulatory and in-patient care,
 +
especially for lump sum billing as ruled under G-DRG (German Diagnosis Related Groups).
 +
 +
Primary care data and routine care data may not just be used for billing but also for further purposes.
 +
Only standardized guidelines support multiple use of such data.
 +
 +
Statistical processing of diagnostic data may e.g. be used for quality assurance and for research,
 +
with diagnoses typically being encoded using classifications, like ICD-10, but also ICD-O and ICF.
 +
 +
For future integrated applications which process structured electronic diagnoses to support medical decision-making processes,
 +
advanced terminologies may have to be used, like e.g. the alphabetical index into ICD and medication/substance directories.
 +
 +
Note 1 TNM- and the UICC-System proved to be insufficient for grading tumors of the central nervous systems because of their low metastasis and the weak relationship between tumor size and its aggressiveness. [Louis 2007]. Therefore we will apply the WHO-Grading (see 6.8)
 +
 
===Scope===
 
===Scope===
 +
 +
Scope of this document is an elementary specification of how to represent diagnoses using HL7 V3 messages and documents.
 +
 +
Diagnoses exactly map from symptoms (diagnostic signs) to terms for diseases.
 +
 +
A a principle HL7 represents diagnoses as observations made by a doctor at a patient, which means that diagnostic data will be modelled using the HL7 Observation class, independent of the V3 model being used.
 +
 +
The goal is to have a model-independent specifiation of how to map relevant diagnostic data into the class Observation.
 +
 +
This document is based on using a structured diagnosis.
 +
 +
* Chapter 3 explains attributes of diagnostic data
 +
* Chapter 4 explains the use of the Observation class
 +
* Chapter 5 focusses on the representation of encoded diagnoses, with section 5.1 mentioning specialties of ICD-10 encding especially in the context of German requirements
 +
* Chapter 6 specifies the representation of diagnoses in tumor documentation.
 +
* Chapter 7 includes examples representations of diagnosis from vrious fields of application.
  
 
==Diagnosis Types==
 
==Diagnosis Types==
 +
 +
===Clarification===
 +
 +
In HL7 Version 3 the term classification of diagnoses means the type or kind of diagnosis, like e.g. "Admission Diagnosis" or "Referral Diagnosis". For clarity, we will use the term "type of diagnosis" in the following text.
 +
 +
===Types of Diagnoses in Ambulatory Care===
 +
 +
====[[Bild:Flag_de.svg|border|27px]] Germany====
 +
The federal association (KBV) of regional statutory billing associations (KV)
 +
for out-patient/ambulatory care in Germany published the so-called KVDT data set as the mandatory format for billing.
 +
It combines billing data (ADT, not to be confused with the HL7 ADT data), the rehab billing data (KADT)
 +
and the statistical data (STDT) of a GPO reporting to its assigned (regional) KV.
 +
Part of the KVDT data set is  a diagnosis specification with the following types of diagnosis
 +
 +
Billing Diagnosis - current diagnosis being the basis for billing
 +
Continued Diagnosis - diagnoses that are valid for more than three quarters (of a year).
 +
 +
Despite these billing diagnoses it is also allowed to send continued diagnoses (more than one quarter)
 +
which are related to the services billed.
 +
Using the record attribute 6001 ("ICD-10-code") for continued diagnoses is not permitted,
 +
instead the attribute 3673 ("continued diagnosis") shall store the ICD-10-code, combined with
 +
attribute 3674 ("reliability - continued diagnosis") and
 +
optionally the attributes 3675("side localization - continued diagnosis")
 +
or , attribute 3676 ("explanation - continued diagnosis") may be used.
 +
Either attributes 6001 or 3673 shall be used.
 +
 +
===Types of Diagnoses for Inpatient Care===
 +
 +
====[[Bild:Flag_de.svg|border|27px]] Deutschland====
 +
 +
The (Federal German Code SGB V) billing law § 301 SGB V states the diagnosis specifications which shall be sent by hospitals
 +
to payors. Based on that law, the data transfer guidance „Datenuebermittlung nach §301“ of the federal hospital association DKG
 +
has been published. This guidance defines different record types (e.g. admission record, discharge record) which also include diagnosis specifications, as given by the following table:
 +
 +
{| class="hl7table"
 +
!Record type
 +
!Segment: Name
 +
!Diagnosis
 +
|-
 +
|Admission Record
 +
|EAD
 +
|Admission Diagnosis
 +
|-
 +
|Indicator for Continuation
 +
|DAU
 +
|Continued Diagnosis - justiyfing sick leave
 +
|-
 +
|Indicator for Continuation
 +
|FAB
 +
|Diagnosis by specialized clinical department
 +
|-
 +
|Discharge Record
 +
|DAU
 +
|Continued Diagnosis - justiyfing sick leave
 +
|-
 +
|Discharge Record
 +
|ETL
 +
|Discharge Diagnosis
 +
|-
 +
|Discharge Record
 +
|NDG
 +
|Concurrent Diagnosis
 +
|-
 +
|Discharge Record
 +
|FAB
 +
|Diagnosis by specialized clinical department
 +
|-
 +
|Outpatient Procedure
 +
|RZA
 +
|Referral diagnosis
 +
|-
 +
|Outpatient Procedure
 +
|BDG
 +
|Treatment diagnosis
 +
|}
 +
 +
As a result this guidance distinguishes the following types of diagnoses under §301 SGB V:
 +
* Admission Diagnosis
 +
* Inpatient Admission Diagnosis
 +
* Special Department Diagnosis
 +
* Continued Diagnosis (with sick leave)
 +
* Discharge Diagnosis
 +
* Special Department Diagnosis Extension
 +
* Referral Diagnosis
 +
* Treatment Diagnosis
 +
 +
Main diagnoses and concurrent diagnoses (as defined by medical aspects) as well as primary and secondary diagnoses shall be represented via additional attributes.
 +
 +
Regarding further diagnosis types please see Annex A
  
 
==Common Diagnosis Descriptions==
 
==Common Diagnosis Descriptions==
 +
 +
===Introduction===
 +
This chapter gives the attributes that are common parts of a structured diagnosis specification which are required for processing an electronic diagnosis information.
 +
 +
===Plain-Text Description===
 +
This attribute describes the diagnosis through  prosaic text, hate.g. may be entered via a text entry field by the medical professional.
 +
This plain text description should be a mandatory part of medical documentation.
 +
 +
Example: Allergic asthma
 +
 +
Note that plain-text descriptions will not necessarily match the associated text of diagnosis codes, like the ones from the systematic classification ICD-10.
 +
 +
 +
===Diagnosis Code===
 +
For the purposes of administrative and statistical processing, diagnoses are being encoded by encoding systems.
 +
E.g. ICD-10 is mandatory under billing according to (Federal German Code) SGB V §391 and §295.
 +
 +
Further systematic encoding systems are e.g. „Alpha-ID“, SNOMED CT and ID MACS.
 +
 +
Example: J45.0
 +
 +
=== Diagnosis Code – Catalog Text===
 +
The catalog text is the associated text for a given diagnosis code. It does not have to match the plain text and can be rendered by an automated system - based on a given diagnosis code.
 +
 +
Example: Predominantly allergic asthma
 +
 +
===Diagnosis Type===
 +
 +
The diagnosis type further specifies the type of a diagnosis and will be given in an encoded form.
 +
Examples may be "referral diagnosis", "admission diagnosis", "discharge diagnosis" etc.
 +
 +
===Diagnosis Date===
 +
This attribute describes date and time when a medical professional made the given diagnosis.
 +
 +
===Documentation Date===
 +
This attribute describes date and time when the diagnosis was documented.
 +
 +
Note that when there is no need to distinguish both dates, the diagnosis date shall be used.
 +
 +
===Specification of the Clinically-Relevant Time of a Diagnosis===
 +
This attribute is a time interval specified by a start time and end time information giving the time in which the patient suffered from the specified disease.
 +
 +
Giving only a start date documents the time since when the patient had that diagnosis.
 +
 +
The start date may be different from the diagnosis date.
 +
 +
Date information in diagnoses may be with different precision.
 +
 +
Examples: Diabetes since 2006
 +
or Fracture of Femur on March 12th, 2007
 +
 +
===Diagnosis Reliability===
 +
This attribute describes the reliability of the specific diagnosis.
 +
 +
====[[Bild:Flag_de.svg|border|27px]] Germany====
 +
 +
For billing under ambulatory/out-patient care (under Federal German Code SGB V) defined
 +
attributes (suffices A, G, V or Z) are compulsory while such attributes are not allowed for
 +
in-patient billing (under Federal German Code SGB V).
 +
 +
===Localization===
 +
 +
The localization attribute specifies in which body site (topography) the disease was diagnosed.
 +
 +
Both plain text or encoded terms are allowed.
 +
 +
An example is the ICD-O site code for tumor documentation.
 +
 +
As a suffix the side may be used.
 +
 +
===Explanations===
 +
 +
This attribute allows medical professionals to document detailed explanations using a plain text.
 +
 +
===Reasons for Exceptions===
 +
 +
This plain-attribute may be required to justify a diagnosis e.g. in the context of billing.
  
 
==Diagnosis Model in HL7 V3==
 
==Diagnosis Model in HL7 V3==
 +
 +
===Summary===
 +
 +
Diagnoses represented in HL7 V3 shall useu the class Observation, which is modelled as shown in fig. 1.
 +
 +
Detailed descriptions of classes and data types in this model can be found in the related HL7 V3 documentation and Data Type Guidelines.
 +
 +
The following sections specifiy how diagnosis attributes shall be mapped into the Observation model.
 +
 +
===Plain Text===
 +
value.originalText diagnosis as a plain text
 +
ST[0..1]
 +
 +
Plain text descriptions of the specific diagnosis shall be stored in the subelement originalText of element value. If it is not necessary to specify a text or should this text not be available, the @nullFlavour attribute shall be used. This element shall explain the reason why there is no plain text. A value of "NAV" states that no coded text is available (yet). More values are described in the HL7 documentation.
 +
 +
The attribute @language of subelement originalText may be used to specify the language of the prosaic diagnosis text.
 +
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- structured representation of diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
    ...
 +
    <value xsi:type="CD" nullFlavor="NAV">
 +
      <originalText>Rektumkarzinom mit Höhenlokalisation ab Anokutanlinie/Linea dentata
 +
      </originalText>
 +
    </value>
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
===Diagnosis Code and Text===
 +
 +
value Diagnosis Code CD[0..1]
 +
 +
Representing a diagnosis via a code and its associated text shall be done va the value element (in the model: an attribute of the Observation class).
 +
 +
The XML attribute @code shall store the diagnosis code and @displayname shall store the associated diagnosis text.
 +
 +
Such a structured representation of e.g. an ICD10 coded diagnosis looks like this:
 +
 +
The XML attribute @codeSystem shall store the OID for the specific ICD-10-GM version being used and the @codeSystemName attribute shall store the plain text name of the coding system and version.
 +
 +
 +
<syntaxhighlight lang="xml">
 +
  <!-- structured representation of diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
  ...
 +
    <!-- ICD-Code of a diagnosis -->
 +
    <value xsi:type="CD" code="I01.0"
 +
      displayName="Akute rheumatische Perikarditis"
 +
      codeSystem="1.2.276.0.76.5.311" codeSystemName="icd10gm2006"/>
 +
    ...
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
===Diagnosis Type===
 +
 +
code classification code CD CW[1..1]
 +
 +
The XML attribute shall specifiy the classification code using the attribute @codeSystem for storing the OID of that coding system (also see Annex <10>)
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- structured representation of diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
    <code code="DX" codeSystem="1.2.276.0.76.5.342"/>
 +
    ...
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
===Diagnosis Date===
 +
author.time Diagnosis Date IVL<TS>[0..1]
 +
 +
The diagnsis date shall specify when the diagnosis was made as the time in the clinical process which is not necessarily the documentation date.
 +
The diagnosis date shall be represented using the author instance which shall be connected via Participation to the current Observation instance.
 +
Instances of author contain a model attribute time of type IVL<TS>.
 +
Detailed information regarding the person giving the diagnosis shall be modelled using an instance of assignedEntity.
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- structured representation of diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
    ...
 +
    <author>
 +
      <!-- Diagnosedatum -->
 +
      <time value="20100111"/>
 +
      <assignedAuthor>
 +
        ...
 +
      </assignedAuthor>
 +
    </author>
 +
    ...
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
===Documentation Date===
 +
dataEnterer.time documentation date TS [1..1]
 +
 +
The documentation is the date when the diagnosis has been entered by e.g. a clinician. The data value is mapped to an instance dataEnterer which is related via a Particpation to the Observation instance (see fig. 1 Observation Model).
 +
 +
The dataEnterer class has an model attribute time of type TS, such that in XML  the data value will be mapped into an element time and an XML attribute @value.
 +
 +
In case there is no dataEnterer instance, the participation relation with its model attribute typeCode=ENT also manages a participationRole instance representing the data entering person that would otherwise be modelled through a instance of dataEnterer.
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- structured representation of diagnosis -->
 +
  <observation classCode="OBS" moodCode="EVN" negationInd="true">
 +
  ...
 +
  <!-- documentation date -->
 +
    <participant typeCode="ENT">
 +
      <time value="20060606"/>
 +
      <participantRole>
 +
        ...
 +
      </participantRole>
 +
    </participant>
 +
    ...
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
===Diagnosis Time Interval===
 +
effectiveTime diagnosis time interval IVL<TS>[0..1]
 +
 +
The model attribute effectiveTime of class Observation specifies the time interval for which the specified is (or, has been) clinically relevant.
 +
 +
In XML, the sub-element low shall specify the begin data and sub-element high shall specifiy the end date. Dates for low or high may also be specified without the other.
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- structured representation of diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
    ...
 +
    <effectiveTime>
 +
      <low value="20050127"/>
 +
    </effectiveTime>
 +
    ...
 +
    </observation>
 +
</syntaxhighlight>
 +
 +
===Diagnosis Reliability===
 +
 +
value.qualifier diagnosis reliability CR [0..1]
 +
 +
the diagnosis reliability shall be represented in the model attribute value using a sub-element qualifier.
 +
 +
<syntaxhighlight lang="xml">
 +
  <!-- structured representation of diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
    ...
 +
    <value xsi:type="CD" nullFlavor="NI">
 +
      <originalText>......</originalText>
 +
      <!--diagnosis reliability -->
 +
      <qualifier>
 +
        <name code="8" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
        <value code="G" codeSystem="2.16.840.1.113883.3.7.1.8"/>
 +
      </qualifier>
 +
    </value>
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
XML attribut @code in name shall specify the name of the diagnosis reliability qualifier, based on the table given below.
 +
XML attribut @codeSystem shall specify the OID of the system giving these qualifier names.
 +
The diagnosis reliability shall be specified using XML attribute @code in the XML element value.
 +
 +
====[[Bild:Flag_de.svg|border|27px]] Germany====
 +
 +
For out-patient care (§ 295 SGB V, Germany) diagnosis reliability attributes are mandatory, while for in-patient care (§ 301 SGB V) they are forbidden i.e. must not be specified. (Source: DIMDI)
 +
 +
{| class="hl7table"
 +
! Code as of §295 SGB V
 +
! Implementation
 +
! Meaning
 +
! Explanation
 +
|-
 +
|G
 +
|
 +
|certain
 +
|diagnosis validated
 +
|-
 +
|V
 +
|uncertaintyCode=UN
 +
|suspicious
 +
|suspicion diagnosis
 +
|-
 +
|Z
 +
|
 +
|state after
 +
|an earlier diagnosis is related
 +
|-
 +
|A
 +
|negationInd=true
 +
|excluded
 +
|this diagnosis has been excluded (use negationInd in Level 3)
 +
|-
 +
|}
 +
 +
Table 2: Vocabulary Domain for Reliability
 +
Codesystem: Sciphox (OID: 2.16.840.1.113883.3.7.1.8)
 +
 +
In tumor documentation the validation of diagnosis is also documented by specifying the (superior) way of diagnosis. This information shall also be specified through the qualifier:
 +
 +
{| class="hl7table"
 +
!Code
 +
!Implementation
 +
!Meaning
 +
!Explanation
 +
|-
 +
|k
 +
|
 +
|clinically
 +
|
 +
|-
 +
|z
 +
|
 +
|zytologically
 +
|
 +
|-
 +
|h
 +
|
 +
|histologically
 +
|
 +
|-
 +
|a
 +
|
 +
|autoptically
 +
|
 +
|-
 +
|d
 +
|
 +
|DCO
 +
|Death certificate only.
 +
|-
 +
|
 +
|nullFlavor = OTH
 +
|Other
 +
|
 +
|-
 +
|
 +
|nullFlavor = NI
 +
|unknown
 +
|
 +
|}
 +
 +
Table 3: Vocabulary Domain for Diagnosis procedure in tumor documentation
 +
Codesystem: (OID: 1.2.276.0.76.5.418)
 +
 +
===Localization===
 +
 +
targetSiteCode Lokalisation
 +
CD CWE [0..1]
 +
 +
Localization of diagnoses shall be specified using the model attribute  targetSiteCode.
 +
For localizations given as plain text the sub-element originalText of targetSiteCode shall be used.
 +
In case no localization code is available, the XML attribute @nullFlavor shall
 +
be specified.
 +
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- structured representation of diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
    ...
 +
    <targetSiteCode nullFlavor="NI">
 +
      <originalText>Oberhalb des rechten Knöchels</originalText>
 +
    </targetSiteCode>
 +
    ...
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
If a structured code is available, then model attribute targetSiteCode shall have a code sub-element with the code being specified in XML attribute @code
 +
and the coding system being specified using XML attribute @codeSystem.
 +
 +
 +
Optionally the XML attribute @displayName may be used to specifiy a plain text for the code and @codeSystemName may be used for the name of the coding system.
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- structured representation of diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
    ...
 +
    <targetSiteCode code="299058009" codeSystem="2.16.840.1.113883.6.96"
 +
    codeSystemName="SNOMED CT" displayName="kleiner Finger">
 +
      <qualifier>
 +
        <name code="78615007" codeSystem="2.16.840.1.113883.6.96"
 +
              codeSystemName="SNOMED CT" displayName="mit Seitenlokalisation"/>
 +
        <value code="24028007" codeSystem="2.16.840.1.113883.6.96"
 +
              codeSystemName="SNOMED CT" displayName="rechts"/>
 +
      </qualifier>
 +
    </targetSiteCode>
 +
    ...
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
Note: The localization codes suggested by the German health Ministry (BMG) shall only be used together with diagnoses encoded in ICD 10 (German).
 +
 +
Additional codes for the side localization may be used in out-patient care as well as in-patient care(see 4).
 +
 +
In tumor documentation further codes shall be use for the side localization:
 +
 +
 +
 +
{| class="hl7table"
 +
! Code
 +
! Implementation
 +
! Meaning
 +
! Explanation
 +
! Common Diagnoses
 +
! Tumor Diagnoses
 +
|-
 +
| R
 +
|
 +
| Right
 +
| side localization right
 +
| X
 +
| X
 +
|-
 +
| L
 +
|
 +
| Left
 +
| side localization left
 +
| X
 +
| X
 +
|-
 +
| B
 +
|
 +
| both side
 +
| diagnosed on both sides
 +
| X
 +
| X
 +
|-
 +
| M
 +
|
 +
| middle line
 +
| middle line zone - 1 inch left or right from middle line
 +
|
 +
| X
 +
|-
 +
|
 +
|nullFlavor = NA
 +
|system disease
 +
|in the sense of 'not applicable'
 +
|
 +
|X
 +
|-
 +
|
 +
|nullFlavor = UNK
 +
|unknown
 +
|
 +
| X
 +
| X
 +
|-
 +
|}
 +
 +
Table 4: Vocabulary Domain for Localization
 +
Coding System: (OID: 1.2.276.0.76.5.412)
 +
 +
4 DIMDI
 +
5 Literatur: Basisdokumentation für Tumorkranke 5. Auflage 1999; Dudeck et al
 +
 +
 +
The side localization is used for diagnosis documentation for common and also for tumor documentation, but with differeent value sets, which are defined as follows:
 +
 +
{| class="hl7table"
 +
! Value Set
 +
! Explanation
 +
! OID
 +
|-
 +
| Common, based on ICD-10
 +
| 2.16.840.1.113883.3.7.1.7
 +
|-
 +
| Tumor Documentation
 +
| 1.2.276.0.76.11.10
 +
|-
 +
|}
 +
 +
Table 5: Value Sets for Localization
 +
 +
===Explanations===
 +
 +
text explanation of diagnosis ST [0..1]
 +
 +
Any explaining text shall be represented using the XML attribute text.
 +
 +
A structured representation will look like this:
 +
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- structured representation of diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
    <value xsi:type="CD" code="J45.0" codeSystem="1.2.276.0.76.5.311"
 +
      displayName="Vorwiegend allergisches Asthma bronchiale">
 +
      <originalText>Allergisches Asthma</originalText>
 +
    </value>
 +
    <text>Intermittierend, seit der Jugend</text>
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
===Reasons for Exceptions===
 +
 +
value Reasons for Exceptions ST [0..1]
 +
 +
Billling-related exceptions shall be encoded using the @value attribute of an extra Observation instance being related via an ActRelation-Ship instance to the original describing instance of Observation.
 +
 +
A structured representation will look like this:
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- structured representation of diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
    ...
 +
    <!-- reason for exception-->
 +
      <entryRelationship typeCode="RSON">
 +
        <observation moodCode="EVN" classCode="OBS">
 +
          <code nullFlavor="UNK"/>
 +
          <value xsi:type="ED">...........</value>
 +
        </observation>
 +
      </entryRelationship>
 +
    ...
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
XML attribute @typeCode shall have the value RSON (= reason) specifying an exception for billing purposes.
 +
 +
===Using more Attributes of Observation===
 +
 +
This section describes more model attributes of Observation that may play a role in describing diagnoses.
 +
 +
====Attribute 'id'====
 +
id diagnosis identificator SET <II>[0..1]
 +
 +
The model attribute id should be used to identify the instance of a diagnosis - which is recommended for computer-based processing of diagnoses in order to refer to the clinical specification of that diagnosis.
 +
 +
In XML representations the XML attribute @extension shall store the diagnosis identifier while the XML attribute @root should specify the OID of the diagnosis database.
 +
 +
In case changes or deletions have to be communicated for this diagnosis instance, this id will provide reference.
 +
 +
====Attribute 'classCode'====
 +
@classCode classCode <= OBS
 +
 +
XML attribute shall be 'OBS' - specifiying Observation as the main type of the Act instance used for documenting the diagnosis.
 +
 +
In XML an attribute @classCode of the element Observation represents the model attribute 'classCode' of class Observation.
 +
 +
====Attribute 'moodCode'====
 +
@moodCode Mood Code <= EVN
 +
 +
Attribute @moodCode specifies how to interpret the containing Act instance.
 +
 +
When using an Observation to specify a diagnosis, the @moodCode shall have the value EVN, indicating that the Observation documents an earlier action.
 +
 +
====Attribute 'negationInd'====
 +
 +
@negationInd Negation Indicator BL [0..1]
 +
 +
The optional attribute @negationInd is of data type BL with values 'true' or 'false'.
 +
 +
Specifying a 'true' value states that the specified diagnosis has been excluded.
 +
 +
@negationInd is optional, the default is 'false'. If not specified, the receiving system will interpret the diagnosis as specified.
 +
 +
====Attribute 'statusCode'====
 +
 +
statusCode Statuscode <= completed
 +
 +
This attribute can be use to represent the state of the containing Act, which can be in states like e.g. "new", "active" or "cancelled". As diagnoses are considered the documentation of an action already completed, the fixed value "completed" shall be used in XML attribute @code of sub-element statusCode.
 +
 +
 +
====An Example====
 +
 +
A small example shows all of the above attributes:
 +
 +
<syntaxhighlight lang="xml">
 +
  <observation classCode="OBS" moodCode="EVN" negationInd="true">
 +
  …
 +
  <statusCode code="completed"/>
 +
  …
 +
  </observation>
 +
</syntaxhighlight>
  
 
==Representation of Diagnosis in specific Codesystems==
 
==Representation of Diagnosis in specific Codesystems==
 +
 +
===ICD-10-GM-coded Diagnoses===
 +
 +
The „International Statistical Classification of Diseases” (ICD) is a
 +
classification system for diseases and related health issues. It has a hierarchical structure. As the german localized version ICD-10-GM is a varient of the ICD-10 released by WHO.
 +
 +
Diseases are specified through alphanumeric codes. Each disease has a unique code and vice versa.
 +
The majority of codes are so-called primary diagnosis keys, i.e.they contain all information to encode a given diagnosis.
 +
 +
====[[Bild:Flag_de.svg|border|27px]] Germany====
 +
 +
ICD also provides the ability to specify secondary keys for additional information. Such secondary keys must only be used together with a primary diagnosis and are marked through asterisk (*) or exclamation (!) as additional codes .
 +
 +
Primary diagnosis codes either have no prefix or a cross (+).
 +
 +
Example.: E14.30+, H28.0* ICD-10 Code for “Diabetes mellitus with cataract“
 +
 +
====Terms of ICD-10 Codes====
 +
ICD-10-GM will be used for encoding diagnoses in both in-patient and ambulatory care. In-patient diagnosis encoding additionally has to adhere to the German coding guidelines (§ 301, Deutsche Codierrichtlinien) and the extensions authorized by the Health Ministry (BMG).
 +
 +
For ambulatory care, the WHO-Table with BMG-extension is to be used.
 +
 +
=====Secondary Codes=====
 +
 +
ICD-10 GM distinguishes between primary codes and secundary codes.
 +
 +
Primary codes are codes without suffix or with a cross(+).
 +
 +
Secondary codes are those codes with an asterisk (*) or an exclam (!).
 +
 +
In oorder to explain their meaning we will translate some quotes of „Basiswissen Kodieren“ [Basic Encoding Knowledge  by DIMDI,www.dimdi.de]
 +
 +
"The code for etiology (cause, origin) of a disease shall be marked with a cross (+)
 +
and its manifestation with an asterisk (*) - with the cross-code being the primary code
 +
and the asterisk-code never being used alone."
 +
 +
Another translated quote:
 +
 +
„ Asterisk codes shall only be those that are marked as explicitly permitted in ICD-10 for the asterisk-suffix."
 +
 +
 +
„ Provided that the secondary code is permitted for asterisk, any other code describing the underlying disease may be used as primary code with the cross-suffix."
 +
 +
„... Some Codes are being marked with an exclam (!) indicating that therse are further descriptions or definitions of the severity. Such codes must not be used alone“ (without primary code).
 +
 +
As a result, each diagnosis must at least have a primary code and optionally secondary codes.
 +
 +
Each primary/secondary code is the alphanumeric string given by ICD-10 code followed by the suffix, either (†, *, !)
 +
 +
=====Side Localization=====
 +
 +
Regarding the encoding of side localizations, we translated a section from „ICD-10-
 +
Bekanntmachung des BMGS“ ("ICD-10 Communications of the German Health Ministry", 2004)
 +
 +
„..for the application of ICD-10-GM the following holds:
 +
When encoding the side localization, the following suffices may be used:
 +
– right: R
 +
– left: L
 +
– both sides: B ...“
 +
[BMGS, 2004]
 +
 +
As a result, for each ICD-10 code, an independent side localization suffix can be appended.
 +
Note: primary code and secondary code can have different side localizations.
 +
 +
Example:
 +
C50.4 R  Mamma Ca - right
 +
J91* L  Pleural effusion in conditions classified elsewhere - left
 +
 +
For tumor documentation the extended table is valid.
 +
 +
=====Reliability of Diagnoses=====
 +
 +
 +
„... When using ICD-10-GM according to § 295 SGB V (ambulatory sector) additionally the following holds:
 +
For encoding the diagnosis reliability one of the follwing suffices must be used:
 +
– for an excluded diagnosis: A
 +
– for a suspected diagnosis: V
 +
– for state (without symptoms) after the given diagnosis: Z
 +
– for a validated diagnosis: G“
 +
[BMGS, 2004, translated by author]
 +
 +
As a result, ambulatory diagnoses used in the context of „Abrechnung ärztlicher Leistungen“
 +
(billing of medical services, fixed term in the German statutory GP system acc. to german federal regulation §295 SGB V)
 +
the specification of diagnosis reliability is mandatory.
 +
 +
For in-patient care these suffices MUST NOT be used.
 +
 +
====Mapping of ICD-10-coded Diagnoses into HL7 v3====
 +
 +
Structured representations of ICD10-encoded diagnoses must support primary and secondary codes, code extensions, side localizations and reliability .
 +
The primary code represents the main disease.
 +
The secondary code extends the primary code and is either used to describe manifestations in organs ("asterisk") or the cause (etiology, e.g. which bacteria) of the main disease ("exclamation")
 +
In order to represent this dependency, an additional oberservation instance will be connected via the ActRelationship to that Observation instance containing the primary code.
 +
 +
So we have the following basic structure for ICD10-encoded diagnoses:
 +
 +
[[Bild:Figure2.jpg|border|27px]]
 +
 +
Figure 2: Class Diagram of ICD-10 Diagnoses in HL7 v3
 +
 +
The attribute typeCode in the ActRelationship shall represent the code extension
 +
 +
The related Observation instance (connected via the ActRelationship) has MFST (Manifestation) as its typeCode in order to represent 'asterisk"-codes.
 +
 +
Exclamation-Code extensions  are being represented as Observation instances connected via ActRelationships with typeCode CAUS (Cause).
 +
 +
The resulting XML structure of an ICD-10 encodeded diagnosis looks like this:
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- Structured Representation of Diagnosis-->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
      …
 +
      <!-- Primary Code-->
 +
      <value xsi:type="CD" code=" E14.30" codeSystem=" 1.2.276.0.76.5.311"/>
 +
      <entryRelationship typeCode="MFST">
 +
        <observation moodCode="EVN" classCode="OBS">
 +
        …
 +
            <!-- Secondary Code-->
 +
            <value xsi:type="CD" code=" H28.0" codeSystem=" 1.2.276.0.76.5.311"/>
 +
        </observation>
 +
      </entryRelationship>
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
In this case the containing ActRelationship instance is of class entryRelationship-
 +
repesented by an element of that name.
 +
 +
Attribute @typeCode has MFST as a fixed value for representing an asterisk code.
 +
 +
value.@code ICD-Code
 +
ST [1..1]
 +
XML-Attribute @code shall store the specific ICD-10 Code.
 +
 +
value.@codeSystem OID of ICD-Codeset
 +
UID [1..1]
 +
XML-Attribute @codeSystem shall keep the OID of the ICD-10 Version being used.
 +
The appendix gives hints towards versions being used in practice.
 +
 +
value.@codeSystemName Name of ICD-10 Version
 +
ST [0..1]
 +
XML-Attribute @codeSystemName may store the Name of the used ICD-10 Version.
 +
 +
value.@displayName ICD-Code Text
 +
ST [0..1]
 +
XML-Attribute @displayName may store the verbose text of the ICD-Code.
 +
 +
OIDs and names of ICD-10 versions may be obtained from DIMDI (www.dimdi.de)
 +
 +
=====Representation of Side Localisation=====
 +
 +
value.qualifier Side Localisation
 +
CR [0..1]
 +
 +
The side localisation code shall be represented using the child element qualifier of the value element, as it refines the specification of that diagnosis code (as decided by HL7 DE TC meeting on 2005-09-01, minutes item 1.3.2).
 +
 +
An example representation looks like this:
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- Structured Representation of a Diagnosis -->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
      <code code="DX" codeSystem=""/>
 +
      <!-- Primary code-->
 +
      <value xsi:type="CD" code="E14.30" codeSystem="1.2.276.0.76.5.311">
 +
        <qualifier>
 +
            <name code="7" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
            <value code="L" codeSystem="2.16.840.1.113883.3.7.1.7"/>
 +
        </qualifier>
 +
      </value>
 +
      <entryRelationship typeCode="CAUS">
 +
        <observation moodCode="EVN" classCode="OBS">
 +
            <code/>
 +
            <!-- Sekundary code-->
 +
            <value xsi:type="CD" code="H28.0" codeSystem="1.2.276.0.76.5.311">
 +
              <qualifier>
 +
                  <name code="7" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
                  <value code="B" codeSystem="2.16.840.1.113883.3.7.1.7"/>
 +
              </qualifier>
 +
            </value>
 +
        </observation>
 +
      </entryRelationship>
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
Child element 'name' within element 'qualifier' defines the type of qualifier.
 +
 +
Therefore, in order to express a qualifier for side localisation, the fixed value „7“ from code system OID 2.16.840.1.113883.3.7.1.0 shall be used:
 +
 +
<syntaxhighlight lang="xml">
 +
  <qualifier>
 +
      <name code="7" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
      <value code="L" codeSystem="2.16.840.1.113883.3.7.1.7"/>
 +
  </qualifier>
 +
</syntaxhighlight>
 +
 +
=====Representation of Diagnosis Reliability =====
 +
 +
value.qualifier Diagnosis Reliability
 +
CR [0..1]
 +
 +
The diagnosis reliability can be considered an extension to the ICD-10 code, shall be represented by the child element qualifier of the value element.
 +
 +
<syntaxhighlight lang="xml">
 +
<!-- Structured Representation of a diagnosis-->
 +
  <observation moodCode="EVN" classCode="OBS">
 +
      <code code="" codeSystem=""/>
 +
      <!-- Primary code-->
 +
      <value xsi:type="CD" code="E14.30" codeSystem="1.2.276.0.76.5.311">
 +
        <qualifier>
 +
            <name code="8" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
            <value code="G" codeSystem="2.16.840.1.113883.3.7.1.8"/>
 +
        </qualifier>
 +
      </value>
 +
      <entryRelationship typeCode="CAUS">
 +
        <observation moodCode="EVN" classCode="OBS" negationInd="true">
 +
            <code/>
 +
            <!-- Secondary code-->
 +
            <value xsi:type="CD" code="H28.0" codeSystem="1.2.276.0.76.5.311">
 +
              <qualifier>
 +
                  <name code="8" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
                  <value code="A" codeSystem="2.16.840.1.113883.3.7.1.8"/>
 +
              </qualifier>
 +
            </value>
 +
        </observation>
 +
      </entryRelationship>
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
Child element 'name' within element 'qualifier' defines the type of qualifier.
 +
 +
Therefore, in order to express a qualifier for diagnosis reliability, the fixed value '8' from code system OID 2.16.840.1.113883.3.7.1.0 shall be used:
 +
 +
Child element 'value' within 'qualifier shall store the respective reliability value.
 +
 +
Possible values are listed in Table 2.
 +
 +
<syntaxhighlight lang="xml">
 +
  <observation classCode="OBS" moodCode="EVN">
 +
      ...
 +
      <value xsi:type="CD" code="A25.1" codeSystem="1.2.276.0.76.5.311" codeSystemName="icd10gm2006">
 +
        <qualifier>
 +
            <name code="8" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
            <value code="G" codeSystem="2.16.840.1.113883.3.7.1.8"/>
 +
        </qualifier>
 +
      </value>
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
When representing an EXCLUDED diagnosis the attribute @negationInd shall be specified as  „true“.
 +
 +
===Specifying a Diagnosis using a Thesaurus Index===
 +
 +
One more way of specifying a diagnosis is by using an index referring to an entry in a medical thesaurus.
 +
 +
 +
====Example: Mapping an Alpha-ID-coded Diagnosis====
 +
 +
=====[[Bild:Flag_de.svg|border|27px]] Germany=====
 +
 +
As an example, the diagnostic thesaurus „Alphabetische Verzeichnis zur ICD-10 GM“ (alphabetic directory of ICD-10 GM) is being used in Germany.
 +
 +
This directory allows to locate a verbose description of ICD-10 terms and to find the corresponding ICD-10 GM code.
 +
 +
The so-called Alpha-ID has been developed to process entries of that alphabetic directory.
 +
 +
It is an identification number for each textual entry in the "alphabetic directory".
 +
 +
In order to find this alpha-ID, a mapping file has been provided by DIMDI (www.dimdi.de).
 +
 +
The Alpha-ID is needed because in medical documentation, the descriptions of diagnoses need to be more differentiated than what ICD-10 codes actually can express.
 +
 +
Using the alpha-ID allows for a much finer granularity of diagnosis descriptions.[DIMDI,Alpha_Id].
 +
 +
As an example the ICD-10 Code “A01.0 Typhus caused by Salmonella typhi“ encodes multiple diagnoses such as „liver typhus“, „lung typhus“ and many more.
 +
 +
By using the Alpha-Id it is possible to specify the specific type of typhus, like e.g. „liver typhus“ as„I18721“ and „lung typhus“ as „I21312“.
 +
 +
  1;I22457;A01.0;;;Darmtyphus
 +
  1;I75303;A01.0;;;Eberth-Krankheit
 +
  1;I71406;A01.0;;;Enteritisches Fieber
 +
  1;I22466;A01.0;;;Enterotyphus
 +
  1;I22467;A01.0;;;Febris enterica
 +
  1;I17704;A01.0;;;Gallenblasentyphus
 +
  1;I71415;A01.0;;;Gastroenteritisches Fieber
 +
  0;I78350;A01.0;;;Gastrointestinale Perforation bei Typhus
 +
  1;I17794;A01.0;;;Gehirntyphus
 +
  1;I21313;A01.0;;;Hauttyphus
 +
  1;I22455;A01.0;;;Ileotyphus
 +
  1;I94981;A01.0;;;Infektion durch Bacterium typhosum
 +
  1;I73671;A01.0;;;Infektion durch Eberthella typhosa
 +
  1;I22458;A01.0;;;Infektion durch Salmonella typhi
 +
  1;I18721;A01.0;;;Lebertyphus
 +
  1;I21312;A01.0;;;Lungentyphus
 +
  1;I96251;A01.0;;;Lymphadenitis mesenterialis durch Salmonella typhi
 +
  1;I66509;A01.0;;;Posttyphoider Abszess
 +
  1;I22456;A01.0;;;Status typhoides
 +
  1;I22463;A01.0;;;Typhoenteritis
 +
  1;I71447;A01.0;;;Typhogastrisches Fieber
 +
  1;I22462;A01.0;;;Typhoides Fieber
 +
  1;I31416;A01.0;;;Typhomanie
 +
  1;I22464;A01.0;;;Typhoperitonitis
 +
  1;I22454;A01.0;;;Typhus
 +
  1;I22461;A01.0;;;Typhus abdominalis
 +
  1;I73926;A01.0;;;Typhusinfektion
 +
 +
Figure 3: Excerpt from mapping file „icd10gm2009_alphaid_edv_ascii20081006.txt“
 +
 +
 +
 +
Figure 4 shows an excerpt of the metafile which defines the fields of the mapping file for the Alpha-Id.
 +
 +
Each record consists of six fields, each being separated by a semicolon.
 +
 +
The fields in each record contain the following data:
 +
 +
  Field 1: Validity (0-not valid, 1-valid)
 +
  Field 2: Stable Identification with prefix I or T ("Alpha-Identifikationsnummer")
 +
  Field 3: Primary key (with cross)
 +
  Field 4: Asterisk key (with asterisk)
 +
  Field 5: Additional key (with exclamation)
 +
  Field 6: Related text
 +
 +
Figure 4: Excerpt from Alpha-ID metafile „icd10gm_alphaid_edv_ascii_liesmich.txt“
 +
 +
 +
A structured representation of a thesaurus uses the @value attribute of class Observation and an example instance lloks like this:
 +
 +
<syntaxhighlight lang="xml">
 +
  <observation moodCode="EVN" classCode="OBS">
 +
  …
 +
  <value xsi:type="CD" code="I2173" codeSystem="1.2.276.0.76.5.309" codeSystemName="alphaid2006"/>
 +
  ...
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
value.@code Alpha-Id
 +
ST [1..1]
 +
XML-Attribute @code stores the index referring to an enty in the „Alphabetisches
 +
Verzeichnis“
 +
 +
value.@codeSystem OID ofAlpha-ID
 +
UID [1..1]
 +
XML-Attribute @codeSystem stores the OID of the Alpha-ID Version being used.
 +
 +
value.@displayName Alpha-Id Text
 +
ST [0..1]
 +
XML-Attribute @displayName may be used to display a text related to the current Alpha-Id
 +
 +
value.@codeSystemName Name of Alpha-ID Version
 +
ST [0..1]
 +
XML-Attribut @codeSystemName represents the Name of the coding system, in our case alphaid2006.
 +
 +
OID and name of ICD-10 Version can be obtained from DIMDI (www.dimdi.de)
 +
 +
===Diagnosis Specification using Identifiers in a Nomenclature===
 +
 +
One way of specififying a diagnosis is to use the code representing a diagnostic term in some medical nomenclature.
 +
 +
A well-known nomenclature in medicine is SNOMED-CT ("systematic nomenclature of medicine - clinical terms")
 +
 +
Compared to ICD-10 it has more concepts for diagnoses and mostly does not classify.
 +
 +
In general using a term of a nomenclature often preserves more information than using a term of a classification.
 +
 +
Classification is selecting a common representation for a set of concepts that are (under some aspect) considered similar.
 +
 +
As a result, classification reduces information, which is demonstrated by the following examples
 +
 +
I.e. as a part of clinical documentation of diagnosis the encoding using alpha-id or some identifier in a nomenclature would be preferred over using a classification like e.g. ICD-10.
 +
 +
The example shows concepts all being represented through the same ICD-10 code Q92.8 for 'Other specified trisomies and partial trisomies of autosomes'.
 +
 +
A simple comparison of codes from nomenclatures gives an example of missing clarity and precision of the ICD-10 classification.
 +
 +
{| class="hl7table"
 +
!Diagnosis
 +
!ICD-10 Code
 +
!Alpha-ID
 +
!Snomed CT
 +
!ID MACS
 +
|-
 +
|Imbalanced Insertion
 +
|Q92.8
 +
|I87548
 +
|254262003
 +
|M002405-D62839-58
 +
|-
 +
|Trisomy 22
 +
|Q92.8
 +
|I81282
 +
|205655003
 +
|M001897-D55549-58
 +
|-
 +
|Trisomy 20
 +
|Q92.8
 +
|I81283
 +
|53346000
 +
|M002406-D55530-58
 +
|-
 +
|Partial Trisomy a.n.k.
 +
|Q92.8
 +
|I81284
 +
|133849008
 +
|M001D1C-C78409-58
 +
|}
 +
 +
Table 6: Diagnoses in different coding systems
 +
 +
 +
=====Precoordinated and Postcoordinated Concepts of a Nomenclature=====
 +
 +
For specifiying a diagnosis using a terminology there are two fundamental approaches:
 +
 +
The pre-coordinated approach selects a fixed term among a comprehensive list with representations for all possible concepts.
 +
 +
The list of all pre-coordinated terms limits the set of concepts which can be represented.
 +
 +
The post-coordinated approach constructs each term out of (more or less independently) encoded aspects of the concept to be represented.
 +
 +
The resulting term is the combination of the encoded aspects of the given concept.
 +
 +
ICD-10 is a good example of a pre-coordinated terminology, as it lists all the terms for the concepts it can represent.
 +
 +
The cross-asterisk extension to ICD-10 is an example of post-coordination.
 +
 +
More info can be found under the Terminfo project [Terminfo] of HL7 International.
 +
 +
====Diagnosis by Thesaurus Index or Term within a Nomenclature====
 +
 +
A term in a nomenclature is specified through the @value attribute of class Observation.
 +
 +
An example (SNOMED CT) of the structured representation looks like this:
 +
 +
<syntaxhighlight lang="xml">
 +
  <observation moodCode="EVN" classCode="OBS">
 +
  ...
 +
  <value
 +
      xsi:type="CD" code="314888007"
 +
      codeSystem="2.16.840.1.113883.6.96"
 +
      codeSystemName="SNOMED CT"
 +
      displayName="Typ-II-Diabetes with diabetic cataract"/>
 +
  ...
 +
  </observation>
 +
</syntaxhighlight>
 +
 +
=====Attribute value.@code Index or Term in Nomenclature=====
 +
CD CWE [1..1]
 +
The XML attribute @code keeps the index referring to an entry in a thesaurus or nomenclature.
 +
 +
=====Attribute value.@codeSystem OID of Nomenclature=====
 +
UID [1..1]
 +
The XML attribute @codeSystem stores the OID of the thesaurus or nomenclature.
 +
 +
=====Attribute value.@displayName Text=====
 +
ST [0..1]
 +
Through the XML attribute @displayName a plain text related to the index can be given.
 +
 +
=====Attribute value.@codeSystemName Name of Nomenclature=====
 +
[0..1]
 +
The XML attribut @codeSystemName describes the name of the thesausrus or nomenclature.
  
 
==Representation of Cancer Diagnosis==
 
==Representation of Cancer Diagnosis==
 
===Introduction===
 
===Introduction===
−
In this chapter, diagnostic aspects in documentation of tumor diseases will be discribed.
+
In this chapter, diagnostic aspects of documentation of tumor diseases will be described.
−
Different aspects of diagnostical discriptions of tumor diseases are discribed by ICD-O (Oncology)
+
Different aspects of diagnostical descriptions of tumor diseases are described by ICD-O (Oncology)
−
and by further classifications to constitute the determination of expansion respectivly of the diseases stage.
+
and by further classifications to document the expansion (tumor spread) or diseases stage, respectively, the latter
−
 
+
one mostly being classified by the TNM-System.  
−
Last one is mostly classified by the TNM-System.  
 
  
 
Especially for hemato oncological diseases (Leukemias and Lymphomas), other systems (e.g. Ann-Arbor-Classification) are used.
 
Especially for hemato oncological diseases (Leukemias and Lymphomas), other systems (e.g. Ann-Arbor-Classification) are used.
 
TNM-System discribes:
 
TNM-System discribes:
  
−
* Expansion of primary tumor (extent repectivly spread in distant organs)
+
* Expansion of primary tumor (extent or, spread in distant organs repectively)
 
* Affection of lymph nodes in lymph flow area
 
* Affection of lymph nodes in lymph flow area
−
* Exisistence of distant metastasis.
+
* Existence of distant metastases.
  
−
For not by TNM – System classifiable diseases or in addition to TNM-System there are a number of further classification systems:
+
For non-TNM–-classifiable diseases or in addition to the TNM-System there are a number of further classification systems:
 
* Ann Arbor
 
* Ann Arbor
 
* Rai
 
* Rai
Zeile 44: Zeile 1.197:
  
 
This list probably will be always incomplete because of the medical progress.
 
This list probably will be always incomplete because of the medical progress.
−
 
  
 
===ICD-O===
 
===ICD-O===
Zeile 87: Zeile 1.239:
  
 
====Tumor Localization====
 
====Tumor Localization====
−
For Tumor-Coding first of all, the site is impotant. It will be classified by the Topography -Axis of ICD-O. Topographical -Codes of ICD-10 are based on chapter II (Neoplasm –C 00 – C 97) of ICD-10.
+
For Tumor-Coding first of all, the site is important. It will be classified by the Topography -Axis of ICD-O. Topographical -Codes of ICD-10 are based on chapter II (Neoplasm –C 00 – C 97) of ICD-10.
 
However, some of the topographical Codes of ICD-10 (Codes) are not used, because their content is discribed by histology- and digit-Codes of ICD-O. (e.g. Differentiation in situ/ infiltrated, melanoma vs. scin cancer).
 
However, some of the topographical Codes of ICD-10 (Codes) are not used, because their content is discribed by histology- and digit-Codes of ICD-O. (e.g. Differentiation in situ/ infiltrated, melanoma vs. scin cancer).
  
Zeile 104: Zeile 1.256:
 
Registration of tumor grading is also provided in TNM.
 
Registration of tumor grading is also provided in TNM.
  
−
====Qualifier of Tumor Formular====
+
====Qualifier of Tumor Formula====
 
ICD-O –Codes can be specified by the following qualifier:
 
ICD-O –Codes can be specified by the following qualifier:
 
   
 
   
Zeile 120: Zeile 1.272:
  
 
===TNM Classification===
 
===TNM Classification===
 +
 +
The TNM classification describes the expansion (spread) of the tumor , i.e. stadium and prognosis of the disease.
 +
 +
As a special feature, the TNM classification uses the same notation for all tumors but supports different interpretations for different entities.
 +
 +
As an example, a T3 for mamma carcinoma has a different interpretation than the stomach carcinoma.
 +
 +
The current edition is 7th which is valid since January 2010, which is a reason why many TNM-6- codes may still be in use.
 +
Therefore all TNM-codes should have a version identifier, because
 +
non translatable differences are in the different editions.
 +
 +
A simple overview can be found in  http://de.wikipedia.org/wiki/TNM.
 +
 +
 +
The T category will be used for the expansion of the primary tumor,
 +
where the stages T0, Tis, T1-T4 und TX are being used, the "higher"
 +
the number, the more progress is being diagnosed and the more adverse the prognosis.
 +
 +
T0 stands for "no primary tumor found" (e.g. because being
 +
eradicated by therapy)
 +
Tis stands for a very early (non-infiltrating) stage tumor
 +
(Tumor in situ) and
 +
TX stands for a diagnosis which can not judge the stage because of missing data
 +
 +
For some tumors subcategories like e.g. T2a, T2b have been defined.
 +
 +
 +
The N-category classifies the affection of lymphatic nodes - usingN0, N1-N3, NX, where N0 means "no lymphatic node affected".
 +
 +
For some tumors, this exclusion ("N0") requires the examination of a minimum amount of nodes.
 +
 +
The higher the N category the more severe is the lymphatic node affection.
 +
 +
If no sufficient data is available NX is being diagnosed.
 +
 +
 +
The M category describes the existence of distant metastases, with the vallues of M0 (no metastases detectable), M1 (metastases detectable) and MX (insufficient data).
 +
 +
 +
The TNM can be used according to clinical criteria (preoperative, cTNM) and according to the pathology findings (pTNM).
 +
 +
For many patients one single diagnoss will be made, either a cTNM or a pTNM, such that this type of finding must be distinguished.
 +
 +
This preoperative ("c" or no prefix) / pathology ("p") attribute can be captured independently for each of the T N M categories.
 +
 +
Therefore the typically used pTNM often meanes pTpNcM, because the spread of a timur can best be diagnosed through surgery while
 +
lymphatic spread only by pathology.
 +
 +
The prefix "r" describes remaining tumors (after non-disease intervals) and a prefix "y" if the classification was assessed after systemic or radiation treatment (ycTNM, ypTNM etc.).
 +
 +
For multiple  Primary tumors the suffix "m" (or the number of tumors) will be put after the T-category value(T2(m), T2(5)).
 +
 +
 +
Therefore a complete TNM formula looks like this:
 +
 +
There are voluntary components e.g. the certainty-Faktor (C-Factor)
 +
 +
Other components require pathology lab examination (L-, V- or Pn-Category)
 +
* y-Symbol (y or empty, disgnosis after systematic or xray treatment)
 +
* r-Symbol (r or empty, remainder)
 +
* p/c/a-Symbol for pT-category (clinical or pathological)
 +
* T-Category
 +
* (m) for multiple localizations or number of tumors
 +
* C-Factor for T-Category (certainty)
 +
 +
* L-Category
 +
* V-Category
 +
* Pn-Category
 +
* p/c/a-Symbol for pN-Category (clinical or pathological)
 +
* N-Category
 +
* C-Factor for N-Category (certainty)
 +
 +
* p/c/a-Symbol für pM-Category
 +
* M-Category
 +
* C-Factor for M-Category (certainty)
 +
* S-Kategorie (serological values, only for testicle tumors)
 +
* UICC-Stadium (Grading via UICC 0 and I-IV together with
 +
letter A, B and C for further classification).
 +
 +
For some tumors further modifiers are being documented as a suffix
 +
(mostly in parenthenses) like e.g. (sn), (mol-),(mol+).
 +
 +
In addition, the TNM supplement introduces innovative or "under test" extensions, which raises doubts whether ta full control of TNM entries.
 +
 +
Typical T-Categories (without pre-/suffices) are being listed in chapter "Sites"
 +
 +
Typical N-Categories (without pre-/suffices) are being listed in chapter "Nodes".
 +
 +
Typical M-Categories (without pre-/suffices) are being listed in chapter "Metastases".
 +
 +
9 Reference: DKFZ
 +
 +
====Qualifiers of the Tumor Formula====
 +
Despite values for T,N and M the TNM formula may also contain various qualifiers.
 +
The following table gives an overview which qualifiers can be used for which information and where they are being used.
 +
This is case-sensitive!
 +
 +
* a Autoptical
 +
* c Clinical
 +
* C C-Factor (certainty)
 +
* G histopathological Grading
 +
* L Lymphatic vessel invasion
 +
* m multiple Tumors
 +
* M distant metastases
 +
* N Regional lymphatic node metastases
 +
* p pathological
 +
* Pn perineural Invasion
 +
* r Rezidiv tumor
 +
* R Residual tumor after treatment
 +
* sn Sentinel-Lymphatic nodes
 +
* Stage Anatomic Stage-Grouping
 +
* T Expansion (spreading) of Primary tumor
 +
* V Venous invasion
 +
* y Classification after initial multi-modal Therapy
 +
 
===Ann Arbor Classification===
 
===Ann Arbor Classification===
 +
 +
For lymphoma the TNM-classification does not make sense and therefore theso-called Ann-Arbor
 +
classification will be applied.
 +
 +
In this system, the stages I-IV are being distinguished, with an additional suffix letter
 +
* A meaning "no general symptoms"
 +
* B "with general symptoms"
 +
* E "extra-lymphatic organ affected"
 +
* S "spleen affected"
 +
 +
As with TNM, the Ann-Arbor classification distinguishes between clinical (cS) and pathological (pS) grading.
 +
 +
According to Durie & Salmon tere are gradings from I to III or the
 +
grades according to SWOG from 1-4 for the "Multiple Myeloma".
 +
 
===FIGO Stages===
 
===FIGO Stages===
 +
 +
FIGO stages ignificantly overlap with the TNM classification, especially on the T-axis.
 +
 +
Therefore no details are being given here.
 +
 
===Gleason Score===
 
===Gleason Score===
 +
 +
The so-called Gleason-Score serves to classify the prostate carcinoma.
 +
The total numeric value is the sum of two indicators for
 +
• loss of differentiation (1-5)
 +
• growth pattern (1-5)
 +
 +
Resulting values range from 2 to 10 (also see Scores & Assessment DSTU).
 +
 +
Furthermore there is a more recent Gleason classification (according to Dhom,
 +
Müller and Helpap [Helpap 2002, Helpap2007]), which also requires to specify
 +
the procedure (esp. the two degrees) being used.
 +
 
===Papanikolaou===
 
===Papanikolaou===
 +
 +
The so-called Pap-Test [Pap] is based on colored cell samples from the cervix and is used as an early indocator for cervical cancers.
 +
 
===WHO Grading===
 
===WHO Grading===
 +
 +
The so-called WHO Grading serves as an individual progonosis on the one hand
 +
and also is an indicator towards further treatment on the other hand.
 +
 +
Tumors of WHO Grade I and II in most cases can be treated by surgery alone,
 +
while tumors with WHO Grading III and IV normally need additional treatment
 +
by radiation or chemotherapie after surgery.
 +
 +
The grading looks like this:
 +
 +
{| class="hl7table"
 +
! Code
 +
! Codename
 +
! Meaning
 +
|-
 +
|I
 +
|
 +
|benign,slow growth of tumor, very good prognosis
 +
|-
 +
|II
 +
|
 +
|still benign, slow growth of tumor,tendency to recur
 +
|-
 +
|III
 +
|
 +
|malignant,actively producing abnormal cells,tends to recur
 +
|-
 +
|IV
 +
|
 +
|very malignant,fast growth,needs systemic therapy, bad prognosis
 +
|}
 +
 +
Table 9: WHO Grading (OID 1.2.276.0.76.5.394)
 +
 +
The fourth edition of the "World Health Organization (WHO)
 +
Classification of tumours of the central nervous system" (2007) lists all
 +
relevant tumor entities.
 +
 +
Also see "Brain Tumor Basics" (http://www.abta.org/sitefiles/sitepages/524309b806778d4f7b79044d97f324ea.pdf)
 +
 
===Conclusion===
 
===Conclusion===
  
 +
The following data of tumors can be represented by these respective classifications (through values and/or modifiers)
 +
 +
 +
{| class="hl7table"
 +
! Concept
 +
! Classification
 +
|-
 +
|Tumor localisation
 +
|ICD-O
 +
|-
 +
|Morphology + dignity
 +
|ICD-O
 +
|-
 +
|Tissue differentiation ICD-O
 +
|ICD-O/TNM
 +
|-
 +
|type of stage codes (c,p,r,y)
 +
|TNM/Ann-Arbor
 +
|-
 +
|T Code + C Factor, multiplicity
 +
|TNM
 +
|-
 +
|M Code + C Factor, multiplicity
 +
|TNM
 +
|-
 +
|N Code + C Factor, multiplicity
 +
|TNM
 +
|-
 +
|Residual Tumor
 +
|TNM
 +
|-
 +
|stage grouping
 +
|TNM/Ann-Arbor/Durie&Salmon/SWOG
 +
|-
 +
|}
 +
 +
==Cancer Diagnosis in HL7 V3==
 +
 +
=== Representing Cancer Diagnoses in HL7 ===
 +
 +
Tumor diagnoses shall be represented in HL7 V3 according to the following schema:
 +
A centralised instance of Observation shall specify the ICD-O code in the 'value' model-attribute
 +
with Dignity and (differentiation) grading in its 'qualifier' sub-element.
 +
 +
Further details shall be represented in more Observation-instances being connected via
 +
supporting ActRelationShip instances with typeCode:=SPRT .
 +
 +
The CertaintyFactor shall be in the 'qualifier' sub-element of the model-attribute 'value'
 +
but only for those Observation instances which represent a T-, N- or M-Classification.
 +
 +
Multiplicity shall be in one more Observation instance related (supporting ActRelationShip)
 +
to that Observation instance representing the T-Classifier.
 +
 +
==== Tree View of HL7-based Representation of Cancer Diagnosis ====
 +
 +
<syntaxhighlight lang="text">
 +
+- ICD-O (Dignity, Grading)
 +
+- T-Category (c, p, r, y)
 +
| +- Multiplicity
 +
+- N-Category (c, p, sn)
 +
| +- Number of nodes examined and marked positive
 +
+- M-Category (c, p)
 +
+- Residual Tumor
 +
+- Grading
 +
+- Cell Type
 +
+- Lymphatic Invasion
 +
+- Venous Invasion
 +
+- Perineural Invasion
 +
+- Staging
 +
+- Ann-Arbor
 +
+- Gleason-Score
 +
</syntaxhighlight>
 +
 +
{| class="hl7table"
 +
!Code
 +
!Codename
 +
!Class / Path
 +
!Representation (Observation or Qualifier)
 +
|-
 +
|DF
 +
|Differenzierungsgrad
 +
|Observation (ICD-O)
 +
|qualifier.@name
 +
|-
 +
|DN
 +
|Dignität
 +
|Observation (ICD-O)
 +
|qualifier.@name
 +
|-
 +
|T
 +
|T
 +
|support-Observation
 +
|Observation/value.@code
 +
|-
 +
|M
 +
|M
 +
|support-Observation
 +
|Observation/value.@code
 +
|-
 +
|N
 +
|N
 +
|support-Observation
 +
|Observation/value.@code
 +
|-
 +
|MP
 +
|Multiplicity
 +
|support-Observation
 +
(T)-support-Observation
 +
|Observation/value.@code
 +
|-
 +
|CF
 +
|Certainty Factor
 +
|support-Observation(T or N or M)
 +
|qualifier.@name
 +
|-
 +
|RS
 +
|Residual tumor
 +
|support-Observation
 +
|Observation/value.@code
 +
|-
 +
|GR
 +
|Grading
 +
|support-Observation
 +
|Observation/value.@code
 +
|-
 +
|LI
 +
|Lymphatic invasion
 +
|support-Observation
 +
|Observation/value.@code
 +
|-
 +
|VI
 +
|Venous invasion
 +
|support-Observation
 +
|Observation/value.@code
 +
|-
 +
|SG
 +
|Staging
 +
|support-Observation
 +
|Observation/value.@code
 +
|-
 +
|AA
 +
|Ann-Arbor-Classification
 +
|support-Observation
 +
|Observation/value.@code
 +
|}
 +
Table 10: Codes for Tumor Diagnoses (OID 1.2.276.0.76.5.334)
 +
 +
=== Example ===
 +
 +
<syntaxhighlight lang="xml">
 +
<observation classCode="OBS" moodCode="EVN">
 +
  ...
 +
  <value xsi:type="CD" code="8070" codeSystem="2.16.840.1.113883.6.43.1"
 +
    displayName="Plattenepithelkarzinom"
 +
    codeSystemName="icd-o-3">
 +
    <qualifier>
 +
      <!-- Dignity -->
 +
      <name code="335" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
      <value code="0" codeSystem="1.2.276.0.76.5.335"/>
 +
    </qualifier>
 +
    <qualifier>
 +
      <!-- Differentiation/Grading -->
 +
      <name code="336" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
      <value code="1" codeSystem="1.2.276.0.76.5.336"/>
 +
    </qualifier>
 +
  </value>
 +
  <!-- Tumor formula -->
 +
  <entryRelationship typeCode="SPRT">
 +
    <observation moodCode="EVN" classCode="OBS">
 +
      <!-- T-Code -->
 +
      <value xsi:type="CD" code="T1" codeSystem="2.16.840.1.113883.15.8" codeSystemName=" tnm5"/>
 +
        <qualifier>
 +
          <name code="341" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
          <value code="C2" codeSystem="1.2.276.0.76.5.341"/>
 +
        </qualifier>
 +
      </value>
 +
    </observation>
 +
  </entryRelationship>
 +
  <entryRelationship typeCode="SPRT">
 +
    <observation moodCode="EVN" classCode="OBS">
 +
    <!-- N-Code -->
 +
      <value xsi:type="CD" code="N2" codeSystem="2.16.840.1.113883.15.8" codeSystemName="tnm5"/>
 +
      </value>
 +
    </observation>
 +
  </entryRelationship>
 +
  <entryRelationship typeCode="SPRT">
 +
    <observation moodCode="EVN" classCode="OBS">
 +
    <!-- M-Code -->
 +
      <value xsi:type="CD" code="M0" displayName="Fernmetastasen nicht vorhanden"
 +
        codeSystem="2.16.840.1.113883.15.8" codeSystemName="tnm5"/>
 +
      </value>
 +
    </observation>
 +
  </entryRelationship>
 +
</observation>
 +
</syntaxhighlight>
 +
 +
= Representation for specific Use Cases =
 +
 +
== Introduction ==
 +
The following sections present examples for structured diagnosis representations in selected applications.
 +
 +
== GP/Ambulatory Billing Diagnosis (Germany) ==
 
   
 
   
−
==Cancer Diagnosis in HL7 V3==
+
This example shows a so-called "KVDT Record"  according to §295 (German Federal Code SGB V) with a diagnosis to be represented through HL7 version 3.
 +
 
 +
Diagnosis fields in the current KVDT record:
 +
 
 +
{| class="hl7table"
 +
!FK
 +
!Usage
 +
!Field Name
 +
!Field Type
 +
!Conditions
 +
!Explanations
 +
|-
 +
|6001
 +
|n
 +
|ICD-Code
 +
|m
 +
|
 +
Rule 486
 +
Rule 488
 +
Rule 489
 +
Rule 490
 +
Rule 492
 +
| see chapter 7
 +
|-
 +
|6003
 +
|1
 +
|Diagnosis Reliability
 +
|m
 +
|Rule 484
 +
| see chapter 7
 +
|-
 +
|6004
 +
|1
 +
|Side Localization
 +
|k
 +
|
 +
| see chapter 7
 +
|-
 +
|6006
 +
|n
 +
|Diagnosis Explanations
 +
|k
 +
|
 +
| see chapter 7
 +
|-
 +
|6008
 +
|n
 +
|Diagnosis Exception Case
 +
|m
 +
|Rule 491
 +
|-
 +
|3673
 +
|n
 +
|Continued Diagnosis (ICD-Code)
 +
|m
 +
|
 +
Rule 486
 +
Rule 488
 +
Rule 489
 +
Rule 490
 +
Rule 492
 +
|
 +
|-
 +
|3674
 +
|1
 +
|Diagnosis Reliability/
 +
Continued Diagnosis
 +
|m
 +
|
 +
|
 +
|-
 +
|3675
 +
|1
 +
|Side Localization
 +
Continued Diagnosis
 +
|k
 +
|
 +
|
 +
|-
 +
|3676
 +
|n
 +
|Diagnosis Explanation
 +
Continued Diagnosis
 +
|k
 +
|
 +
|
 +
|-
 +
|3677
 +
|n
 +
|Diagnosis Exception Case
 +
Continued Diagnosis
 +
|m
 +
|Regel 491
 +
|
 +
|-
 +
|}
 +
Table 11: GP/Ambulatory Billing Diagnoses (Germany) ref 10,11
 +
 
 +
Multiple ICD-10 codes may be specified - without a (mandatory) check of its medical validity
 +
but with at least one primary ICD-10 code being required.
 +
 
 +
With each code, a ide localization, a diagnosis reliability, diagnosis explanations
 +
and exception cases may be specified.
 +
 
 +
Control code 6001 indicates a (current) billing diagnosis, while
 +
control code 3673 indicates a continued diagnosis.
 +
 
 +
* 10 FK: Field (control) code
 +
* 11 m = MANDATORY, k = OPTIONAL
 +
 
 +
=== Example in HL7-V3:===
 +
 
 +
<syntaxhighlight lang="xml">
 +
<!-- Diagnose (Abrechnungsdiagnose) 6001-->
 +
<!-- :A17.0+;G01*;;Tuberkulöse Meningitis Gesichert Rechts-->
 +
<!-- Diagnose 1***************************************************************-->
 +
…
 +
<observation classCode="OBS" moodCode="EVN">
 +
  <!-- Code für Abbrechungsdiagnose 6001-->
 +
  <code code="XXX_DX" codeSystem="2.16.840.1.113883.5.4"/>
 +
  <!-- Diagnoseerläuterung 6006**********************************************-->
 +
  <text/>
 +
  <!-- Primärcode 6001*******************************************************-->
 +
  <value xsi:type="CD" code="A17.0" codeSystem="1.2.276.0.76.5.311"
 +
    codeSystemName="icd10gm2006">
 +
    <!-- Diagnosesicherheit 6003-->
 +
    <qualifier>
 +
      <name code="DSH" codeSystem="111.111.1.1.1"/>
 +
      <value code="G" codeSystem="1.2.276.0.76.3.1.1.5.1.21"/>
 +
    </qualifier>
 +
    <!-- Seitenlokalisation 6004-->
 +
    <qualifier>
 +
      <name code="SL" codeSystem="111.111.1.1.1"/>
 +
      <value code="R" codeSystem="1.2.276.0.76.3.1.1.5.1.22"/>
 +
    </qualifier>
 +
  </value>
 +
  <!-- Ausnahmetatbestand zu Primärcode**************************************-->
 +
  <entryRelationship typeCode="RSON">
 +
    <observation classCode="OBS" moodCode="EVN">
 +
      <code nullFlavor="NI"/>
 +
      <value xsi:type="ST">…</value>
 +
    </observation>
 +
  </entryRelationship>
 +
  <entryRelationship typeCode="MFST">
 +
  <!-- Sekundärcode 6001*************************************************-->
 +
    <observation classCode="OBS" moodCode="EVN">
 +
      <code code="XXX_DX" codeSystem="2.16.840.1.113883.5.4"/>
 +
      <!-- Diagnoseerläuterung 6006**************************************-->
 +
      <text>Diagnoseerläuterung</text>
 +
      <value xsi:type="CD" code="G01" codeSystem="1.2.276.0.76.5.311" codeSystemName="icd10gm2006">
 +
        <!-- Diagnosesicherheit 6003-->
 +
        <qualifier>
 +
          <name code="DSH" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
          <value code="G" codeSystem="1.2.276.0.76.3.1.1.5.1.21"/>
 +
        </qualifier>
 +
        <!-- Seitenlokalisation 6004-->
 +
        <qualifier>
 +
          <name code="SL" codeSystem="2.16.840.1.113883.3.7.1.0"/>
 +
          <value code="R" codeSystem="1.2.276.0.76.3.1.1.5.1.22"/>
 +
        </qualifier>
 +
      </value>
 +
      <!-- Ausnahmebegründung zum Sekundärcode 6008***********************-->
 +
      <entryRelationship typeCode="RSON">
 +
        <observation classCode="OBS" moodCode="EVN">
 +
          <code nullFlavor="NI"/>
 +
          <value xsi:type="ST">…</value>
 +
        </observation>
 +
      </entryRelationship>
 +
    </observation>
 +
  </entryRelationship>
 +
</observation>
 +
</syntaxhighlight>
 +
 
 +
==Diagnosis in the Referral Letter / Medical Documentation==
 +
The Implementation Guideline „Arztbrief“ (www.hl7.de) as well as related documents lists various examples
 +
of how to represent diagnoses via HL7 V3/CDA Release 2
 +
(see [CDAr2Arztbrief]).
 +
 
 +
= Terminology =
 +
== Introduction ==
 +
This chapter separates codes in use from normative specifications, in order to allow updates to such codes without having to rewrite the normative part. Therefore this chapter is just informative. Current codes have to be requested.
 +
{|
 +
|-
 +
!Due to pending third-party copy rights regarding some of the the following tables, the textual descriptions may not be given here such that the respective fields remain empty.
 +
|}
 +
 
 +
== Overview of Value Sets ==
 +
 
 +
{| class="hl7table"
 +
! Value Sets
 +
! OID
 +
! Short Term
 +
! German
 +
! English
 +
|-
 +
|Tumors
 +
|1.2.276.0.76.11.1
 +
|uicctumor
 +
|ValueSet für Tumore in der Tumordokumentation
 +
|ValueSet for tumors in the cancer documentation
 +
|-
 +
|Nodes
 +
|1.2.276.0.76.11.2
 +
|uiccodes
 +
|ValueSet für Knoten in der Tumordokumentation
 +
|ValueSet for nodes in the cancer documentation
 +
|-
 +
|Metastases
 +
|1.2.276.0.76.11.3
 +
|uiccmetastasen
 +
|ValueSet für Metastasen in der Tumordokumentation
 +
|ValueSet for metastases in the cancer documentation
 +
|-
 +
|ResidualTumor
 +
|1.2.276.0.76.11.4
 +
|uiccresidualtumor
 +
|ValueSet für Residualtumor in der Tumordokumentation
 +
|ValueSet for residual tumor in the cancer documentation
 +
|-
 +
|Stage Classification
 +
|1.2.276.0.76.11.5
 +
|uiccstages
 +
|ValueSet für die Stadiengruppier ung in der Tumordokumentation
 +
|ValueSet for stages in the cancer documentation
 +
|-
 +
|Venous Invasion
 +
|1.2.276.0.76.11.6
 +
|uiccveneninvasion
 +
|ValueSet für die Veneninvasion in der Tumordokumentation
 +
|ValueSet for venous invasion in the cancer documentation
 +
|-
 +
|Lymphatic Invasion
 +
|1.2.276.0.76.11.7
 +
|uicclymphsysteminvasion
 +
|ValueSet für die Lymphsysteminvasion in der Tumordokumentation
 +
|ValueSet for the lymphatic system invasion in the cancer documentation
 +
|-
 +
|Perineural Invasion
 +
|1.2.276.0.76.11.8
 +
|uiccneuralscheideninvasion
 +
|ValueSet für die Neuralscheideninvasion in der Tumordokumentation
 +
|ValueSet for the perineural invasion in the cancer documentation
 +
|-
 +
|TNM Qualifier
 +
|1.2.276.0.76.11.9
 +
|uicctnmqualifier
 +
|ValueSet für die TNM-Qualifier in der Tumordokumentation
 +
|ValueSet for tnm qualifier in the cancer documentation
 +
|-
 +
|TNM Localisation for Tumor Documentation
 +
|1.2.276.0.76.11.10
 +
|uicclocalisation
 +
|ValueSet für die TNM-Seitenlokalisation in der Tumordokumentation
 +
|ValueSet for tnm localisation in the cancer documentation
 +
|}
 +
Table 12: Value Sets
 +
 
 +
UICC 5. Edition (OID 2.16.840.1.113883.15.8)
 +
UICC 6. Edition (OID 2.16.840.1.113883.15.7)
 +
UICC 7. Edition (OID 2.16.840.1.113883.15.6)
 +
 
 +
 
 +
== Overview of Coding Schemata ==
 +
 
 +
{| class="hl7table"
 +
!Vocabulary Domain/Coding System
 +
!OID
 +
!Short Term
 +
|-
 +
|ICD10GM
 +
|
 +
|
 +
|-
 +
|ICD­10 GM Version 2012
 +
|1.2.276.0.76.5.409
 +
|icd10gm2012
 +
|-
 +
|ICD­10 GM Version 2011
 +
|1.2.276.0.76.5.388
 +
|icd10gm2011
 +
|-
 +
|ICD­10 GM Version 2010
 +
|1.2.276.0.76.5.384
 +
|icd10gm2010
 +
|-
 +
|ICD­10 GM Version 2009
 +
|1.2.276.0.76.5.356
 +
|icd10gm2009
 +
|-
 +
|ICD­10 GM Version 2008
 +
|1.2.276.0.76.5.330
 +
|icd10gm2008
 +
|-
 +
|ICD­10 GM Version 2007
 +
|1.2.276.0.76.5.318
 +
|icd10gm2007
 +
|-
 +
|ICD­10 GM Version 2006
 +
|1.2.276.0.76.5.311
 +
|icd10gm2006
 +
|-
 +
|ICD­O
 +
|
 +
|
 +
|-
 +
|ICD­O­3
 +
|2.16.840.1.113883.6.43.1
 +
|icd­o­3
 +
|-
 +
|ICD­O­DA­1978
 +
|n.a.
 +
|
 +
|-
 +
|ICD­O­DA­2002
 +
|n.a.
 +
|
 +
|-
 +
|TNM
 +
|
 +
|
 +
|-
 +
|C­Faktor
 +
|1.2.276.0.76.5.341
 +
|c­faktor­tumor
 +
|-
 +
|TNM 5. Edition
 +
|2.16.840.1.113883.15.8
 +
|tnm5
 +
|-
 +
|TNM 6. Edition
 +
|2.16.840.1.113883.15.7
 +
|tnm6
 +
|-
 +
|TNM 7. Edition
 +
|2.16.840.1.113883.15.6
 +
|tnm7
 +
|-
 +
|Dignity
 +
|1.2.276.0.76.5.335
 +
|dignitaet­tumor
 +
|-
 +
|Cell­ Type
 +
|1.2.276.0.76.5.???
 +
|
 +
|-
 +
|Validity R­Classification
 +
|1.2.276.0.76.5.???
 +
|
 +
|-
 +
|Existence of Residual Tumor
 +
|1.2.276.0.76.5.???
 +
|
 +
|-
 +
|Tumor Diagnoses
 +
|1.2.276.0.76.5.334
 +
|tumordiagnosen
 +
|-
 +
|Grading
 +
|1.2.276.0.76.5.336
 +
|grading_tumor
 +
|-
 +
|­Localisation of Metastases
 +
|1.2.276.0.76.5.401
 +
|
 +
|-
 +
|Scores
 +
|
 +
|
 +
|-
 +
|Gleason­Score
 +
|
 +
|
 +
|-
 +
|Gleason­Score: Loss of Differentiation
 +
|1.2.276.0.76.5.402
 +
|
 +
|-
 +
|Gleason­Score: Growth Pattern
 +
|1.2.276.0.76.5.403
 +
|
 +
|-
 +
|Gleason­Score: Grading
 +
|1.2.276.0.76.5.404
 +
|
 +
|-
 +
|Ann­Arbor
 +
|1.2.276.0.76.5.405
 +
|
 +
|-
 +
|Papanikolaou: Grading
 +
|1.2.276.0.76.5.406
 +
|
 +
|-
 +
|Alpha­ID
 +
|
 +
|
 +
|-
 +
|Alpha­ID 2012
 +
|1.2.276.0.76.5.408
 +
|alphaid2012
 +
|-
 +
|Alpha­ID 2011
 +
|1.2.276.0.76.5.387
 +
|alphaid2011
 +
|-
 +
|Alpha­ID 2010
 +
|1.2.276.0.76.5.383
 +
|alphaid2010
 +
|-
 +
|Alpha­ID 2009
 +
|1.2.276.0.76.5.355
 +
|alphaid2009
 +
|-
 +
|Alpha­ID 2008
 +
|1.2.276.0.76.5.329
 +
|alphaid2008
 +
|-
 +
|Alpha­ID 2007
 +
|1.2.276.0.76.5.316
 +
|alphaid2007
 +
|-
 +
|Alpha­ID 2006
 +
|1.2.276.0.76.5.309
 +
|alphaid2006
 +
|-
 +
|MeSH
 +
|
 +
|
 +
|-
 +
|MeSH
 +
|2.16.840.1.113883.6.177.5
 +
|MSHGER
 +
|-
 +
|Snomed CT
 +
|
 +
|
 +
|-
 +
|SNOMED CT
 +
|2.16.840.1.113883.6.96
 +
|SNOMED CT
 +
|-
 +
|ID Macs
 +
|
 +
|
 +
|-
 +
|ID Macs
 +
|1.2.276.0.76.5.305
 +
|id_macs
 +
|-
 +
|
 +
|
 +
|
 +
|-
 +
|Typing Diagnosis
 +
|1.2.276.0.76.5.342
 +
|}
 +
Table 13: Coding Schemata
 +
 
 +
== Diagnosis Types In Germany ==
 +
The following codes are being used for typing of diagnoses.
 +
This table is a pragmatic collection of the current state-of-the-art in german systems. An international classification is not available at this time.
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Meaning
 +
|-
 +
|DX
 +
|Diagnosis, not specified any further
 +
|-
 +
|  RFFDX
 +
|Referral Diagnosis
 +
|-
 +
|  ENTDX
 +
|Entry Diagnosis
 +
|-
 +
|  TRFDX
 +
|Transfer Diagnosis
 +
|-
 +
|  ADMDX
 +
|Admittance Diagnosis
 +
|-
 +
|  CDDX
 +
|Clinical Department’s Diagnosis
 +
|-
 +
|    CDXDX
 +
|Clinical Department’s extra Diagnosis
 +
|-
 +
|    CDTDX
 +
|Clinical Department’s Treatment Diagnosis
 +
|-
 +
|    CDDISDX
 +
|Clinical Department’s Discharge Diagnosis
 +
|-
 +
|    CDADMDX
 +
|Clinical Department’s Admittance Diagnosis
 +
|-
 +
|  SUCCDX
 +
|Successive Diagnosis (with continuing sick leave)
 +
|-
 +
|  DISDX
 +
|Discharge Diagnosis
 +
|-
 +
|  TDX
 +
|Transfer Diagnosis
 +
|-
 +
|  PERMDX
 +
|Permanent Diagnosis
 +
|-
 +
|    APERMDX
 +
|Anamnestic Permanent Diagnosis
 +
|-
 +
|    BPERMDX
 +
|Treatment-related Permanent Diagnosis
 +
|-
 +
|    EMERDX
 +
|Emergency-related Diagnosis
 +
|-
 +
|  REIMDX
 +
|Reimbursement Diagnosis
 +
|-
 +
|  POSTOPDX
 +
|Post-operative Diagnosis
 +
|-
 +
|  PREOPDX
 +
|Pre-operative Diagnosis
 +
|-
 +
|  ADR
 +
|UAW ­Observed Unwanted Side Effects
 +
|-
 +
|  ADRPD
 +
|UAW Main Disease
 +
|-
 +
|  ADRCCD
 +
|UAW Side Disease  
 +
|-
 +
|  IFSGDX
 +
|If–G ­Diagnoses
 +
|-
 +
|  IFSGSUSPDX
 +
|If–G ­Suspicious Diagnoses
 +
|-
 +
|  IFSGDD
 +
|If–G ­Differential Diagnoses
 +
|-
 +
|  COD
 +
|Cause of Death (fatal disease)
 +
|-
 +
|  CCCOND
 +
|Accompanying Diseases
 +
|-
 +
|  EXTCS
 +
|External Cause
 +
|-
 +
|  NEO
 +
|Neoblasts
 +
|-
 +
|  UAE
 +
|Unwanted Medication Event
 +
|-
 +
|    UAW
 +
|Unwanted Medication Effect12
 +
|-
 +
|  CAREDX
 +
|Care Diagnosis
 +
|-
 +
|  SYMDX
 +
|Symptom
 +
|-
 +
|  OTHDX
 +
|Miscellaneous Diagnosis
 +
|}
 +
Table 14: Diagnosis Types (OID 1.2.276.0.76.5.342)
 +
 
 +
== ICD-O Codes ==
 +
=== Dignity ===
 +
Dignity refers to a tumor property related to their biological behavior in the body. 13
 +
{| class="hl7table"
 +
!Meaning
 +
!Code
 +
|-
 +
|0
 +
|benign
 +
|-
 +
|1
 +
|Neoplasm with uncertain or unknown behaviour
 +
|-
 +
|2
 +
|Carcinoma in situ
 +
|-
 +
|3
 +
|malign, Primary Tumor
 +
|-
 +
|6
 +
|malign, Metastasis
 +
|-
 +
|9
 +
|malign, not differentiated between Primary Tumor or Metastasis
 +
|}
 +
Table 15: Dignity Codes (OID 1.2.276.0.76.5.335)
 +
 
 +
12 In this case, a cause has to be documented along with the diagnosis – but that is not covered in this implementation guide. It also has to be clarified whether such diagnosis is equal to “suspicious for”.
 +
13 DIMDI www.dimdi.de ICD10GM, ICDO3
 +
 +
 
 +
 
 +
=== Grade of Differentiation/Grading ===
 +
The following table lists possible gradings. The entity column lists to what tumor entities these grades apply. ref.14
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!German
 +
!Entity
 +
|-
 +
|0
 +
|Primary acquired melanosis
 +
|
 +
|Malignant Melanoma of Conjunctiva
 +
|-
 +
|1
 +
|well differentiated
 +
|Gut differenziert
 +
|all but Prostata, Malignant Melanoma of Conjunctiva
 +
|-
 +
|
 +
|Well differentiated (slight anaplasia) (Gleason 2­4)
 +
|
 +
|Prostata
 +
|-
 +
|
 +
|Malignant melanoma arising from a naevus
 +
|
 +
|Malignant Melanoma of Conjunctiva
 +
|-
 +
|2
 +
|moderately differentiated
 +
|Mäßig differenziert
 +
|all but Prostata, Malignant Melanoma of Conjunctiva
 +
|-
 +
|
 +
|Moderately differentiated (moderate anaplasia) (Gleason 5–6)
 +
|
 +
|Prostata
 +
|-
 +
|
 +
|Malignant melanoma arising from primary acquired melanosis
 +
|
 +
|Malignant Melanoma of Conjunctiva
 +
|-
 +
|3
 +
|poorly differentiated
 +
|Schlecht differenziert
 +
|all but Prostata, Penis, Kidney, Renal Pelvis and Ureter, Urinary Bladder, Urethra, Malignant Melanoma of Conjunctiva
 +
|-
 +
|
 +
|Malignant melanoma arising de novo
 +
|
 +
|Malignant Melanoma of Conjunctiva
 +
|-
 +
|3­4
 +
|Poorly differentiated/ undifferentiated (marked anaplasia) (Gleason 7– 10)
 +
|
 +
|Prostata
 +
|-
 +
|
 +
|Poorly differentiated/ undifferentiated
 +
|
 +
|Penis, Kidney, Renal Pelvis and Ureter, Urinary Bladder, Urethra
 +
|-
 +
|4
 +
|undifferentiated
 +
|Undifferenziert
 +
|all but Prostata, Penis, Kidney, Renal Pelvis and Ureter, Urinary Bladder, Urethra, Malignant Melanoma of Conjunctiva
 +
|-
 +
|9
 +
|
 +
|
 +
|Grading not performed, not given or not applicable
 +
|-
 +
|L
 +
|low malignity  (G1­G2)
 +
|Niedriggradig maligne (G1­G2)
 +
|
 +
|-
 +
|M
 +
|intermediate malignity (G2­G3)
 +
|Mittelgradig maligne (G2­G3)
 +
|
 +
|-
 +
|H
 +
|high malignity (G3­G4)
 +
|Hochgradig maligne (G3G4)
 +
|
 +
|-
 +
|B
 +
|Borderline
 +
|Grenzfall
 +
|
 +
|-
 +
|X
 +
|grade of differentiation cannot be assessed
 +
|Differenzierungs­grad nicht be­stimmbar
 +
|}
 +
 
 +
{|
 +
|-
 +
!This Grading may either be a qualifier in a containing ICDO or be documented as a component in a stand-alone code.
 +
|}
 +
Table 16:Grade of Differentiation/Gradings (OID 1.2.276.0.76.5.336)
 +
14 DIMDI www.dimdi.de ICD-O-3
 +
 
 +
 
 +
=== Cell Type ===
 +
This qualifier identifies the immune phenotype related to a lymphoma.
 +
{| class="hl7table"
 +
!Code
 +
!Meaning
 +
!Explanation  
 +
|-
 +
|T
 +
|T­ cell type
 +
|affects T ­lymphocytes
 +
|-
 +
|B
 +
|B­ cell type
 +
|affects B lymphocytes
 +
|-
 +
|N  
 +
|Null cell type
 +
|[[NHL]]  Th0, null cell type lymphoma (and T-cell)
 +
|-
 +
|K
 +
|Natural­ Killer cell type  
 +
|affects NK­ cells: rare lymphoma, mostly in nose or of nasal type
 +
|-
 +
|X
 +
|
 +
|not determineable (undifferentiated lymphoma)
 +
|-
 +
|9
 +
|
 +
|affected cell type determination not performed, not specified or not applicable
 +
|-
 +
|U
 +
|
 +
|unknown, nullFlavor=UNK
 +
|}
 +
Table 17: Lymphoma-Affected Cell Type (OID 1.2.276.0.76.5.???)
 +
 
 +
=== Validity of R Classification ===
 +
This qualifier documents the focus of the Residual¬ Classification15.
 +
{| class="hl7table"
 +
!Code
 +
!Meaning
 +
!Explanation  
 +
|-
 +
|L
 +
|locoregionary tumor
 +
|nearby tumor(s)
 +
|-
 +
|M
 +
|distant metastasis
 +
|distant secondary tumors
 +
|-
 +
|G
 +
|overall phenomenon
 +
|
 +
|}
 +
Table 18: Validity of R-Classifikation (OID 1.2.276.0.76.5.???)
 +
15 Altmann based on TNM V7, Giessen, 2010
 +
 
 +
=== Existence of Residual Tumor ===
 +
This qualifier indicates, where a Residual Tumor exists ref. 16.
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Meaning
 +
!Explanation
 +
|-
 +
|L
 +
|locoregionary tumor
 +
|nearby tumor(s)
 +
|-
 +
|F
 +
|distant metastasis
 +
|distant secondary tumors
 +
|-
 +
|B
 +
|both
 +
|
 +
|-
 +
|U
 +
|unknown
 +
|nullFlavor=UNK
 +
|}
 +
Existence of residual Tumor
 +
 
 +
16 Dudeck J. Basisdokumentation für Tumorerkrankte. Giessen. 1999.
 +
 
 +
== Codes for TNM-Classification ==
 +
{{NoteBox|The TNM classification according to UICC is being a codesystem as a whole. Therefore all tables share the same OID for documentation purposes.
 +
 
 +
An easy way to handle this is the definition of value sets, each with the respective permitted values.
 +
Each code may only be used in some documentation if the respective UICC edition is checkmarked in our table– which states that the respective code is a part of that edition.}}
 +
 
 +
=== Tumors ===
 +
This section lists known T-Categories ref. 17 (without representing possible extensions). Descriptions vary with the related entity. Codes shall be used along with tumor diagnosis, as one code may have different meanings. (e.g. T1 may refer to 23 cm or 24 cm).
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!Explanation
 +
!5.
 +
!6.
 +
!7.
 +
|-
 +
|Ta
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|Tis
 +
|Carcinoma in situ
 +
|non invasive
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T0
 +
|No evidence of primary tumour
 +
|
 +
|
 +
|X
 +
|X
 +
|-
 +
|T1
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T1mic
 +
|
 +
|micro invasion
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T1a
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T1a1
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T1a2
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T1b
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T1b1
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T1b2
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T1c
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T1d
 +
|
 +
|
 +
|
 +
|
 +
|X
 +
|-
 +
|T2
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T2a
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T2a1
 +
|
 +
|
 +
|
 +
|
 +
|X
 +
|-
 +
|T2a2
 +
|
 +
|
 +
|
 +
|
 +
|X
 +
|-
 +
|T2b
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T2c
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T2d
 +
|
 +
|
 +
|
 +
|
 +
|X
 +
|-
 +
|T3
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T3a
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T3b
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T3c
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T3d
 +
|
 +
|
 +
|
 +
|X
 +
|X
 +
|-
 +
|T4
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T4a
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T4b
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T4c
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T4d
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|T4e
 +
|
 +
|
 +
|
 +
|
 +
|X
 +
|-
 +
|TX
 +
|Primary tumor cannot be assessed
 +
|Stage of primary tumor cannot be determined
 +
|
 +
|
 +
|
 +
|}
 +
Table 20: (T) Tumor Codes Value Set (OID 1.2.276.0.76.11.1)
 +
17 TNM 5.,6.,7. Edition
 +
 
 +
=== Nodes ===
 +
Any code for involvement of lymph nodes shall only be used together with tumor diagnosis.
 +
 
 +
{| class="hl7table"
 +
!
 +
!
 +
!
 +
!
 +
!UICC
 +
!UICC
 +
!UICC
 +
|-
 +
!Code
 +
!Description
 +
!Meaning
 +
!Entity
 +
!5.
 +
!6.
 +
!7.
 +
|-
 +
|N0
 +
|No regional lymph node metastasis
 +
|no lymph node affected
 +
|all
 +
|X
 +
|X
 +
|X
 +
|-
 +
|N1
 +
|
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|N1mi
 +
|Bilateral regional lymph node metastasis
 +
|
 +
|vulva
 +
|
 +
|X
 +
|X
 +
|-
 +
|N1a
 +
|
 +
|
 +
|all
 +
|X
 +
|X
 +
|X
 +
|-
 +
|N1b
 +
|
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|N1b1
 +
|
 +
|
 +
|
 +
|X
 +
|
 +
|
 +
|-
 +
|N1b2
 +
|
 +
|
 +
|
 +
|X
 +
|
 +
|
 +
|-
 +
|N1b3
 +
|
 +
|
 +
|
 +
|X
 +
|
 +
|
 +
|-
 +
|N1b4
 +
|
 +
|
 +
|
 +
|X
 +
|
 +
|
 +
|-
 +
|N1c
 +
|
 +
|
 +
|
 +
|
 +
|X
 +
|X
 +
|-
 +
|N2
 +
|
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|}
 +
Table 21: (N) Lymph Node Codes Value Set (OID 1.2.276.0.76.11.2)
 +
 
 +
=== Metastasis ===
 +
Code describing distant metastases shall only be used together with tumor diagnosis.
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!German
 +
!Entity
 +
!5.
 +
!6.
 +
!7.
 +
|-
 +
!
 +
!
 +
!
 +
!
 +
!UICC
 +
!UICC
 +
!UICC
 +
|-
 +
|M0
 +
|No distant metastasis
 +
|Fernmetastasen nicht vorhanden
 +
|all
 +
|X
 +
|X
 +
|X
 +
|-
 +
|M1
 +
|Distant metastasis
 +
|Fernmetastasen vorhanden
 +
|all
 +
|X
 +
|X
 +
|X
 +
|-
 +
|M1a
 +
|
 +
|
 +
|only oesophagus / prostate
 +
|X
 +
|X
 +
|X
 +
|-
 +
|M1b
 +
|
 +
|
 +
|only  oesophagus / prostate
 +
|X
 +
|X
 +
|X
 +
|-
 +
|M1c
 +
|
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|M1d
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|X
 +
|-
 +
|M1e
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|X
 +
|-
 +
|MX
 +
|Distant metastasis cannot be assessed
 +
|
 +
|all
 +
|X
 +
|X
 +
|X
 +
|}
 +
Table 22: (M) Metastasis Code Value Set (OID 1.2.276.0.76.11.3)
 +
 
 +
=== Residual Tumor ===
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!German
 +
|-
 +
|R0
 +
|No residual tumour
 +
|kein Residualtumor
 +
|-
 +
|R1
 +
|Microscopic residual tumour
 +
|nur mikroskopisch  Residualtumor nachweisbar
 +
|-
 +
|R2
 +
|Macroscopic residual tumour and
 +
|makroskopischer Residualtumor und
 +
|-
 +
|R2a
 +
| microscopically not confirmed
 +
|­mikroskopisch nicht bestätigt
 +
|-
 +
|R2b
 +
| microscopically confirmed
 +
|­mikroskopisch bestätigt
 +
|-
 +
|RX
 +
|Presence of residual tumour cannot be assessed
 +
|Unbekannt
 +
|}
 +
Table 23: Residualtumor Codes Value Set (OID 1.2.276.0.76.11.4)
 +
 
 +
=== Stage grading as of UICC ===
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!Meaning
 +
!5.
 +
!6.
 +
!7.
 +
|-
 +
|
 +
|
 +
|
 +
! colspan=3 | UICC
 +
|-
 +
|okk
 +
|
 +
|TX, N0, M0
 +
|X
 +
|X
 +
|X
 +
|-
 +
|0
 +
|Carcinoma in situ
 +
|Tis, N0, M0
 +
|X
 +
|X
 +
|X
 +
|-
 +
|0a
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|0is
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|I
 +
|
 +
|
 +
|
 +
|X
 +
|X
 +
|-
 +
|IA
 +
|
 +
|T1, N0, M0
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IA1
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IA2
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IB
 +
|
 +
|T2, N0, M0
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IB1
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IB2
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IC
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|II
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IIA
 +
|
 +
|T1, N1, M0
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IIA1
 +
|
 +
|
 +
|
 +
|
 +
|X
 +
|-
 +
|IIA2
 +
|
 +
|
 +
|
 +
|
 +
|X
 +
|-
 +
|IIB
 +
|
 +
|T2, N1, M0
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IIC
 +
|
 +
|T3, N0, M0
 +
|X
 +
|X
 +
|X
 +
|-
 +
|III
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IIIA
 +
|
 +
|T1, N2, M0
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IIIA
 +
|
 +
|T2, N2, M0
 +
|
 +
|
 +
|
 +
|-
 +
|IIIA
 +
|
 +
|T3, N1,2, M0
 +
|
 +
|
 +
|
 +
|-
 +
|IIIB
 +
|
 +
|T4, each N, M0
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IIIB
 +
|
 +
|each T, N3, M0
 +
|
 +
|
 +
|
 +
|-
 +
|IIIC
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IS
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IV
 +
|
 +
|each T, each N, M1
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IVA
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IVB
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|IVC
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|not defined
 +
|
 +
|
 +
|X
 +
|X
 +
|X
 +
|-
 +
|not recommended
 +
|
 +
|
 +
|
 +
|X
 +
|X
 +
|}
 +
Table 24: Stage Classification ref. 18 Value Set (OID 1.2.276.0.76.11.5)
 +
 
 +
18 In: Schmoll HJ, Höffken K, Possinger K eds. Kompendium Internistische Onkologie. „Collection of Internistic Oncology “. Springer. 4. Edition; 2006
 +
 
 +
=== Venous Invasion ===
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!German
 +
|-
 +
|V0
 +
|no venous invasion
 +
|keine Veneninvasion
 +
|-
 +
|V1
 +
|microscopic venous invasion
 +
|mikroskopische Veneninvasion
 +
|-
 +
|V2
 +
|macroscopic venous invasion
 +
|makroskopische Veneninvasion
 +
|-
 +
|VX
 +
|venous invasion cannot be assessed
 +
|Veneninvasion nicht feststellbar
 +
|}
 +
Table 25: Venous Invasion Code Value Set (OID 1.2.276.0.76.11.6)
 +
 
 +
=== Lymphatic System Invasion ===
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!German
 +
|-
 +
|L0
 +
|no lymphatic invasion
 +
|keine Lymphsysteminvasion
 +
|-
 +
|L1
 +
|lymphatic invasion
 +
|Lymphsysteminvasion
 +
|-
 +
|LX
 +
|lmphatic invasion cannot be assessed
 +
|Lymphsysteminvasion nicht fest­stellbar
 +
|}
 +
Table 26: Lymphatic Invasion Codes Value Set (OID 1.2.276.0.76.11.7)
 +
 
 +
=== Perineural Invasion ===
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!German
 +
|-
 +
|Pn0
 +
|no perineural invasion
 +
|keine perineurale Invasion
 +
|-
 +
|Pn1
 +
|Perineural invasion
 +
|perineurale Invasion
 +
|-
 +
|PnX
 +
|unknown
 +
|Unbekannt
 +
|}
 +
Table 27: Perineural Invasion Code Value Set (OID 1.2.276.0.76.11.8)
 +
 
 +
=== Qualifier ===
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!German
 +
|-
 +
|c
 +
|Assessment according to clinical criteria
 +
|Beurteilung nach klinischen Kriterien
 +
|-
 +
|p
 +
|according to the pathological results
 +
|nach dem pathologischen Befund
 +
|-
 +
|r
 +
|TNM result of recurrent tumor
 +
|TNM­Befund für Rezidivtumor
 +
|-
 +
|y
 +
|Classification of initial multimodal therapy
 +
|Klassifikation nach initialer multi­modaler Therapie
 +
|}
 +
Table 28: TNM-Qualifier Value Set (OID 1.2.276.0.76.11.9)
 +
 
 +
=== Certainty ===
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description of Evidence
 +
!German
 +
|-
 +
|C1
 +
|Evidence from standard diagnostic means (e.g., inspection, palpation, and standard radiography, intraluminal endoscopy for tumours of certain organs)
 +
|Nachweis durch diagnostische Standardmethoden (Inspektion, Palpation, einfache Röntgenaufnahmen)
 +
|-
 +
|C2
 +
|Evidence obtained by special diagnostic means (e.g., radiographic imaging in special projections, tomography, computerized tomography [CT], ultrasonography, lymphography, angiography,scintigraphy,magnetic resonance imaging [MRI],endoscopy, biopsy, and cytology)
 +
|Nachweis durch spezielle klinische diagnostische Methoden einschließlich Computertomogramm, Magnet­Resonanz­Tomographie
 +
|-
 +
|C3
 +
|Evidence from surgical exploration, including biopsy and cytology
 +
|Nachweis durch Operation, einschließlich Biopsie und Zytologie
 +
|-
 +
|C4
 +
|Evidence of the extent of disease following definitive surgery and pathological examination of the resected specimen
 +
|Nachweis durch operative Behandlung mit pathologischer Untersuchung der entnommenen Gewebeteile
 +
|-
 +
|C5
 +
|Evidence from autopsy
 +
|Nachweis durch Autopsie
 +
|}
 +
Table 29: Certainty Factor Codes (OID 1.2.276.0.76.5.341)
 +
 
 +
=== Localisation of Distant Tumours / Metastases ===
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!German
 +
!Explanation
 +
|-
 +
|PUL
 +
|Pulmonary
 +
|Pulmonal
 +
|Lungenmetastase
 +
|-
 +
|OSS
 +
|Osseous
 +
|Ossär
 +
|Knochenmetastase
 +
|-
 +
|HEP
 +
|Hepatic
 +
|Hepatisch
 +
|Lebermetastase
 +
|-
 +
|BRA
 +
|Brain
 +
|Cerebral
 +
|Hirnmetastase
 +
|-
 +
|LYM
 +
|Lymph Nodes
 +
|Lymphonodulär
 +
|Lymphknotenmetastase
 +
|-
 +
|OTH
 +
|Others
 +
|Andere
 +
|Andere Metastase
 +
|-
 +
|MAR
 +
|Bone Marrow
 +
|Medullär
 +
|Knochenmarkmetastase
 +
|-
 +
|PLE
 +
|Pleura
 +
|Pleural
 +
|RippenfellMetastase
 +
|-
 +
|ADR
 +
|Adrenals
 +
|Adrenal
 +
|Nebennierenmetastase
 +
|-
 +
|SKI
 +
|Skin
 +
|dermal
 +
|Hautmetastase
 +
|}
 +
Table 30: Metastases Localisation Codes (OID 1.2.276.0.76.5.401)
 +
 
 +
== Codes for Gleason Score ==
 +
 
 +
The Gleason Grading system helps evaluating the prognosis of men with prostate cancer, as a part of a strategy of prostate cancer staging which predicts prognosis and guides therapy. The Gleason score is based on microscopic findings.
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
!German
 +
|-
 +
|1
 +
|Round to oval equal individual glands, lying close to each other, sharply demarcated from the surrounding area
 +
|Runde bis ovale gleich große Einzeldrüsen, dicht nebeneinander liegend, scharf gegen die Umgebung abgegrenzt
 +
|-
 +
|2
 +
|Slightly less uniform single glands, separated by small amounts of stroma, less sharply defined tumor margin
 +
|Etwas weniger uniforme Einzeldrüsen, getrennt durch geringe Mengen von Stroma, weniger scharf begrenzter Tumorrand
 +
|-
 +
|3
 +
|a) Irregularly large and irregularly shaped glands, usually with abundant stroma, sometimes also stored tightly irregular and indistinct tumor border
 +
|Unregelmäßig große und unregelmäßig gestaltete Drüsen mit gewöhnlich reichlicherem Stroma, gelegentlich auch dicht gelagert, unregelmäßige und unscharfe Tumorgrenze
 +
|-
 +
|
 +
|b) Papillary or cribriform structures, sometimes in large gang­like formations
 +
|Papilläre oder kribriforme Strukturen, z.T. in großen gangähnlichen Bildungen
 +
|-
 +
|4
 +
|"a) Large irregular epithel formations by glandular fusion (""fused glands"") and branched glands with irregular infiltration into the surrounding area "
 +
|Große unregelmäßige Epithelformationen durch Drüsenverschmelzung („fused glands“) sowie verzweigte Drüsen mit unregelmäßiger Infiltration in die Umgebung
 +
|-
 +
|
 +
|b) Adenocarcinoma with prominent clear cytoplasm similar to clear cell adenocarcinomas of the kidney
 +
|Adenokarzinom mit ausgeprägt klarem Zytoplasma ähnlich hellzelligen Adenokarzinomen der Niere
 +
|-
 +
|5
 +
|a) Circumscribed round epithelial clusters with mostly solid and cribriform construction, usually with central necrosis
 +
|Scharf begrenzte runde Epithelhaufen mit meist solidem und kribriformem Bau, gewöhnlich mit zentraler Nekrose
 +
|-
 +
|
 +
|(comedo carcinoma­like)
 +
|(komedo­karzinomähnlich)
 +
|-
 +
|
 +
|b) Irregularly shaped formations of an undifferentiated carcinoma, which only just discernible glandular formation or is identified vacuoles (signet ring­like) than adenocarcinoma
 +
|Unregelmäßig begrenzte Formationen eines undifferenzierten Karzinoms, das nur durch gerade noch erkennbare Drüsenbildung oder Vakuolen (siegelringähnlich) als Adenokarzinom zu identifizieren ist
 +
|}
 +
Table 31: Loss of Differentiation according to Gleason Score ref. 19 (OID 1.2.276.0.76.5.402)
 +
 
 +
Documentation by the GleasonSum (Gleason¬Score) as the sum of the two most dominating findings: Uniformly structured tumors: two times the points of above table. Non-uniformly structured tumors: points for the dominating share of findings (so-called primary grading) + points for second-largest share (secondary grading), if  punch biopsy show more than two grades, the second component will be based on the most adverse component found.
 +
 
 +
19: Dt. Gesellschaft f. Urologie e.V.
 +
 
 +
== Ann Arbor Codes ==
 +
The tumor staging system for lymphomas.
 +
 
 +
Principal Stages
 +
 
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
|-
 +
|I
 +
|cancer is located in a single region, usually one lymph node and the surrounding area
 +
|-
 +
|II
 +
|cancer is located in two separate regions, an affected lymph node or organ and a second affected area, and that both affected areas are confined to one side of the diaphragm
 +
|-
 +
|III
 +
|cancer has spread to both sides of the diaphragm, including one organ or area near the lymph nodes or the spleen
 +
|-
 +
|IV
 +
|diffuse or disseminated involvement of one or more extralymphatic organs
 +
|}
 +
Table 33: Ann Arbor (OID 1.2.276.0.76.5.405)
 +
 
 +
Modifiers for Constitutional Symptoms
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
|-
 +
|A
 +
|absence of constitutional symptoms is denoted by adding an ""A"" 
 +
|-
 +
|B
 +
|presence of constitutional (B-type) symptoms is denoted by adding a ""B""
 +
|}
 +
Table 34: Ann Arbor constitutional  symptoms (OID 1.2.276.0.76.5.416 {{Alert|Falsche OID: 1.2.276.0.76.5.416 ist atcgm2013))}}
 +
 
 +
Modifiers for Spread of Tumor
 +
{| class="hl7table"
 +
!Code
 +
!Description
 +
|-
 +
|E
 +
|disease is ""extranodal"" (not in the lymph nodes) or has spread from lymph nodes to adjacent tissue.
 +
|-
 +
|S
 +
|the disease has spread to the spleen.
 +
|-
 +
|X
 +
|the largest deposit is >10 cm large (""bulky disease""), or the mediastinum is wider than 1/3 of the chest on a chest X-ray.
 +
|}
 +
Table 35: Ann Arbor Extensions for Spreading in Organs  Code Set (OID 1.2.276.0.76.5.417) {{Alert|Falsche OID: 1.2.276.0.76.5.417 ist icd10gm2014}}
  
−
==Representation for specific Use Cases==
+
== Papanicolaou Coding ==
  
−
==Terminology==
+
Results of the so-called Pap-Test
−
===Introduction===
 
−
===...===
 
  
−
==Appendix A: Other==
+
{| class="hl7table"
 +
!Code
 +
!Meaning
 +
|-
 +
|Pap0
 +
|non representative sample
 +
|-
 +
|PapI
 +
|normal cell findings
 +
|-
 +
|PapII
 +
|atypical, benign disorder, infection, metaplasia, atrrophy, bacteria, viruses,
 +
|-
 +
|PapIIw
 +
|insufficient samples
 +
|-
 +
|PapIII
 +
|cell proliferation and atypic cells
 +
|-
 +
|PapIIID
 +
|dysplastic , mostly with HPV infection
 +
|-
 +
|PapIIIG
 +
|moderate/severe dyskaryosis and/or dysplasia
 +
|-
 +
|PapIV
 +
|biopsy sample and histological clarification required
 +
|-
 +
|PapIVa
 +
|carcinoma in situ
 +
|-
 +
|PapIVb
 +
|single certain tumour cells, carcinoma very certain
 +
|-
 +
|PapV
 +
|many certain tumour cells, carcinoma certain, cellular changes suggestive of invasive squamous carcinoma, and cellular changes indicative of adenocarcinoma of the uterine cervix and other invasive cancer.
 +
|}
  
−
==Appendix B: Indices==
+
Table 36: Grading according to Papanicolaou (OID 1.2.276.0.76.5.406)

Aktuelle Version vom 11. November 2014, 11:52 Uhr

Under construction icon-blue.svg This article or section is in the middle of an expansion or major restructuring and is not yet ready for use. You are welcome to assist in its construction by editing it as well. If this article has not been edited in several days, please remove this template.
This article was last edited by Wikiadmin (talk| contribs) 10 years ago. (Purge)
Diese Seite oder Abschnitt ist derzeit ein Entwurf und ist noch nicht fertiggestellt. Du bist eingeladen, bei der Fertigstellung mitzuwirken. Wenn dieser Beitrag länger als einige Tage nicht editiert wurde, entferne diese Vorlage.
This article was last edited by Wikiadmin (talk| contribs) 10 years ago. (Purge)
Information icon.svg Representation of Diagnosis based on the Clinical Document Architecture Rel.2 for Healthcare in Germany Version 1.1


Inhaltsverzeichnis

Introduction

Introduction

Documentation of diagnoses is an essential part of many workflows in healthcare systems.

The ways of documenting a diagnosis may depend on the purpose such as medical, statistical, research-related, legal or administrative purposes.

This guideline focusses on the structured electronic documentation of diagnoses for the following applications:

Flag de.svg Germany

Fields of application for diagnosis documentation in Germany are e.g.

  • Capturing a diagnosis for the purpose of billing an ICD-10-GM code under Federal German Code SGB V
    • under law §301 for in-patients
    • under law §295 for out-patients /ambulatory care
    • under law §140 for integrated care plans ("IGV-MVZ")
  • Cause-of-death statistics based on ICD-10 WHO
  • Quality assurance as of law §137 SGB V and related hospital quality reports
  • Infectious disease reporting as required under Infektionsschutz-Gesetz
  • Epidemiology and cancer registers (using ICD-O), including further classification of tumor diseases (1)
  • Expertise by payor for the purpose of retirement plans and statutory insurances (using e.g. ICF)
  • Medical documentation in healthcare such as referral letters, admission letters, sick-leave-notes, prescriptions, in-patient EHRs
  • Clinical studies (MedDRA, WHO-Art)
  • Payor Risk Compensation as of "Risikostrukturausgleich" ruling
  • Product detail information for medication, such as indications, counter-indications amd sideeffects ("UAW")

Administrative documentation of diagnoses will be required for justifying the billing of therapy such as treatment/procedures.

Since Jan 1st 2000 the classification ICD-10 GM as mandatory for diagnosis encoding in both ambulatory and in-patient care, especially for lump sum billing as ruled under G-DRG (German Diagnosis Related Groups).

Primary care data and routine care data may not just be used for billing but also for further purposes. Only standardized guidelines support multiple use of such data.

Statistical processing of diagnostic data may e.g. be used for quality assurance and for research, with diagnoses typically being encoded using classifications, like ICD-10, but also ICD-O and ICF.

For future integrated applications which process structured electronic diagnoses to support medical decision-making processes, advanced terminologies may have to be used, like e.g. the alphabetical index into ICD and medication/substance directories.

Note 1 TNM- and the UICC-System proved to be insufficient for grading tumors of the central nervous systems because of their low metastasis and the weak relationship between tumor size and its aggressiveness. [Louis 2007]. Therefore we will apply the WHO-Grading (see 6.8)

Scope

Scope of this document is an elementary specification of how to represent diagnoses using HL7 V3 messages and documents.

Diagnoses exactly map from symptoms (diagnostic signs) to terms for diseases.

A a principle HL7 represents diagnoses as observations made by a doctor at a patient, which means that diagnostic data will be modelled using the HL7 Observation class, independent of the V3 model being used.

The goal is to have a model-independent specifiation of how to map relevant diagnostic data into the class Observation.

This document is based on using a structured diagnosis.

  • Chapter 3 explains attributes of diagnostic data
  • Chapter 4 explains the use of the Observation class
  • Chapter 5 focusses on the representation of encoded diagnoses, with section 5.1 mentioning specialties of ICD-10 encding especially in the context of German requirements
  • Chapter 6 specifies the representation of diagnoses in tumor documentation.
  • Chapter 7 includes examples representations of diagnosis from vrious fields of application.

Diagnosis Types

Clarification

In HL7 Version 3 the term classification of diagnoses means the type or kind of diagnosis, like e.g. "Admission Diagnosis" or "Referral Diagnosis". For clarity, we will use the term "type of diagnosis" in the following text.

Types of Diagnoses in Ambulatory Care

Flag de.svg Germany

The federal association (KBV) of regional statutory billing associations (KV) for out-patient/ambulatory care in Germany published the so-called KVDT data set as the mandatory format for billing. It combines billing data (ADT, not to be confused with the HL7 ADT data), the rehab billing data (KADT) and the statistical data (STDT) of a GPO reporting to its assigned (regional) KV. Part of the KVDT data set is a diagnosis specification with the following types of diagnosis

Billing Diagnosis - current diagnosis being the basis for billing Continued Diagnosis - diagnoses that are valid for more than three quarters (of a year).

Despite these billing diagnoses it is also allowed to send continued diagnoses (more than one quarter) which are related to the services billed. Using the record attribute 6001 ("ICD-10-code") for continued diagnoses is not permitted, instead the attribute 3673 ("continued diagnosis") shall store the ICD-10-code, combined with attribute 3674 ("reliability - continued diagnosis") and optionally the attributes 3675("side localization - continued diagnosis") or , attribute 3676 ("explanation - continued diagnosis") may be used. Either attributes 6001 or 3673 shall be used.

Types of Diagnoses for Inpatient Care

Flag de.svg Deutschland

The (Federal German Code SGB V) billing law § 301 SGB V states the diagnosis specifications which shall be sent by hospitals to payors. Based on that law, the data transfer guidance „Datenuebermittlung nach §301“ of the federal hospital association DKG has been published. This guidance defines different record types (e.g. admission record, discharge record) which also include diagnosis specifications, as given by the following table:

Record type Segment: Name Diagnosis
Admission Record EAD Admission Diagnosis
Indicator for Continuation DAU Continued Diagnosis - justiyfing sick leave
Indicator for Continuation FAB Diagnosis by specialized clinical department
Discharge Record DAU Continued Diagnosis - justiyfing sick leave
Discharge Record ETL Discharge Diagnosis
Discharge Record NDG Concurrent Diagnosis
Discharge Record FAB Diagnosis by specialized clinical department
Outpatient Procedure RZA Referral diagnosis
Outpatient Procedure BDG Treatment diagnosis

As a result this guidance distinguishes the following types of diagnoses under §301 SGB V:

  • Admission Diagnosis
  • Inpatient Admission Diagnosis
  • Special Department Diagnosis
  • Continued Diagnosis (with sick leave)
  • Discharge Diagnosis
  • Special Department Diagnosis Extension
  • Referral Diagnosis
  • Treatment Diagnosis

Main diagnoses and concurrent diagnoses (as defined by medical aspects) as well as primary and secondary diagnoses shall be represented via additional attributes.

Regarding further diagnosis types please see Annex A

Common Diagnosis Descriptions

Introduction

This chapter gives the attributes that are common parts of a structured diagnosis specification which are required for processing an electronic diagnosis information.

Plain-Text Description

This attribute describes the diagnosis through prosaic text, hate.g. may be entered via a text entry field by the medical professional. This plain text description should be a mandatory part of medical documentation.

Example: Allergic asthma

Note that plain-text descriptions will not necessarily match the associated text of diagnosis codes, like the ones from the systematic classification ICD-10.


Diagnosis Code

For the purposes of administrative and statistical processing, diagnoses are being encoded by encoding systems. E.g. ICD-10 is mandatory under billing according to (Federal German Code) SGB V §391 and §295.

Further systematic encoding systems are e.g. „Alpha-ID“, SNOMED CT and ID MACS.

Example: J45.0

Diagnosis Code – Catalog Text

The catalog text is the associated text for a given diagnosis code. It does not have to match the plain text and can be rendered by an automated system - based on a given diagnosis code.

Example: Predominantly allergic asthma

Diagnosis Type

The diagnosis type further specifies the type of a diagnosis and will be given in an encoded form. Examples may be "referral diagnosis", "admission diagnosis", "discharge diagnosis" etc.

Diagnosis Date

This attribute describes date and time when a medical professional made the given diagnosis.

Documentation Date

This attribute describes date and time when the diagnosis was documented.

Note that when there is no need to distinguish both dates, the diagnosis date shall be used.

Specification of the Clinically-Relevant Time of a Diagnosis

This attribute is a time interval specified by a start time and end time information giving the time in which the patient suffered from the specified disease.

Giving only a start date documents the time since when the patient had that diagnosis.

The start date may be different from the diagnosis date.

Date information in diagnoses may be with different precision.

Examples: Diabetes since 2006 or Fracture of Femur on March 12th, 2007

Diagnosis Reliability

This attribute describes the reliability of the specific diagnosis.

Flag de.svg Germany

For billing under ambulatory/out-patient care (under Federal German Code SGB V) defined attributes (suffices A, G, V or Z) are compulsory while such attributes are not allowed for in-patient billing (under Federal German Code SGB V).

Localization

The localization attribute specifies in which body site (topography) the disease was diagnosed.

Both plain text or encoded terms are allowed.

An example is the ICD-O site code for tumor documentation.

As a suffix the side may be used.

Explanations

This attribute allows medical professionals to document detailed explanations using a plain text.

Reasons for Exceptions

This plain-attribute may be required to justify a diagnosis e.g. in the context of billing.

Diagnosis Model in HL7 V3

Summary

Diagnoses represented in HL7 V3 shall useu the class Observation, which is modelled as shown in fig. 1.

Detailed descriptions of classes and data types in this model can be found in the related HL7 V3 documentation and Data Type Guidelines.

The following sections specifiy how diagnosis attributes shall be mapped into the Observation model.

Plain Text

value.originalText diagnosis as a plain text ST[0..1]

Plain text descriptions of the specific diagnosis shall be stored in the subelement originalText of element value. If it is not necessary to specify a text or should this text not be available, the @nullFlavour attribute shall be used. This element shall explain the reason why there is no plain text. A value of "NAV" states that no coded text is available (yet). More values are described in the HL7 documentation.

The attribute @language of subelement originalText may be used to specify the language of the prosaic diagnosis text. 


<!-- structured representation of diagnosis -->
  <observation moodCode="EVN" classCode="OBS">
    ...
    <value xsi:type="CD" nullFlavor="NAV">
      <originalText>Rektumkarzinom mit Höhenlokalisation ab Anokutanlinie/Linea dentata
      </originalText>
    </value>
  </observation>

Diagnosis Code and Text

value Diagnosis Code CD[0..1]

Representing a diagnosis via a code and its associated text shall be done va the value element (in the model: an attribute of the Observation class).

The XML attribute @code shall store the diagnosis code and @displayname shall store the associated diagnosis text.

Such a structured representation of e.g. an ICD10 coded diagnosis looks like this:

The XML attribute @codeSystem shall store the OID for the specific ICD-10-GM version being used and the @codeSystemName attribute shall store the plain text name of the coding system and version. 


  <!-- structured representation of diagnosis -->
  <observation moodCode="EVN" classCode="OBS">
  ...
    <!-- ICD-Code of a diagnosis -->
    <value xsi:type="CD" code="I01.0"
      displayName="Akute rheumatische Perikarditis"
      codeSystem="1.2.276.0.76.5.311" codeSystemName="icd10gm2006"/>
    ...
  </observation>

Diagnosis Type

code classification code CD CW[1..1]

The XML attribute shall specifiy the classification code using the attribute @codeSystem for storing the OID of that coding system (also see Annex <10>) 

<!-- structured representation of diagnosis -->
  <observation moodCode="EVN" classCode="OBS">
     <code code="DX" codeSystem="1.2.276.0.76.5.342"/>
     ...
  </observation>

Diagnosis Date

author.time Diagnosis Date IVL<TS>[0..1]

The diagnsis date shall specify when the diagnosis was made as the time in the clinical process which is not necessarily the documentation date. The diagnosis date shall be represented using the author instance which shall be connected via Participation to the current Observation instance. Instances of author contain a model attribute time of type IVL<TS>. Detailed information regarding the person giving the diagnosis shall be modelled using an instance of assignedEntity. 

<!-- structured representation of diagnosis -->
  <observation moodCode="EVN" classCode="OBS">
    ...
    <author>
      <!-- Diagnosedatum -->
      <time value="20100111"/>
      <assignedAuthor>
        ...
      </assignedAuthor>
    </author>
    ...
  </observation>

Documentation Date

dataEnterer.time documentation date TS [1..1]

The documentation is the date when the diagnosis has been entered by e.g. a clinician. The data value is mapped to an instance dataEnterer which is related via a Particpation to the Observation instance (see fig. 1 Observation Model).

The dataEnterer class has an model attribute time of type TS, such that in XML the data value will be mapped into an element time and an XML attribute @value.

In case there is no dataEnterer instance, the participation relation with its model attribute typeCode=ENT also manages a participationRole instance representing the data entering person that would otherwise be modelled through a instance of dataEnterer. 

<!-- structured representation of diagnosis -->
  <observation classCode="OBS" moodCode="EVN" negationInd="true">
  ...
  <!-- documentation date -->
    <participant typeCode="ENT">
      <time value="20060606"/>
      <participantRole>
        ...
      </participantRole>
    </participant>
    ...
  </observation>

Diagnosis Time Interval

effectiveTime diagnosis time interval IVL<TS>[0..1]

The model attribute effectiveTime of class Observation specifies the time interval for which the specified is (or, has been) clinically relevant.

In XML, the sub-element low shall specify the begin data and sub-element high shall specifiy the end date. Dates for low or high may also be specified without the other. 

<!-- structured representation of diagnosis -->
  <observation moodCode="EVN" classCode="OBS">
    ...
    <effectiveTime>
       <low value="20050127"/>
    </effectiveTime>
    ...
    </observation>

Diagnosis Reliability

value.qualifier diagnosis reliability CR [0..1]

the diagnosis reliability shall be represented in the model attribute value using a sub-element qualifier. 

   <!-- structured representation of diagnosis -->
  <observation moodCode="EVN" classCode="OBS">
    ...
    <value xsi:type="CD" nullFlavor="NI">
      <originalText>......</originalText>
      <!--diagnosis reliability -->
      <qualifier>
        <name code="8" codeSystem="2.16.840.1.113883.3.7.1.0"/>
        <value code="G" codeSystem="2.16.840.1.113883.3.7.1.8"/>
      </qualifier>
    </value>
  </observation>

XML attribut @code in name shall specify the name of the diagnosis reliability qualifier, based on the table given below. XML attribut @codeSystem shall specify the OID of the system giving these qualifier names. The diagnosis reliability shall be specified using XML attribute @code in the XML element value.

Flag de.svg Germany

For out-patient care (§ 295 SGB V, Germany) diagnosis reliability attributes are mandatory, while for in-patient care (§ 301 SGB V) they are forbidden i.e. must not be specified. (Source: DIMDI)

Code as of §295 SGB V Implementation Meaning Explanation
G certain diagnosis validated
V uncertaintyCode=UN suspicious suspicion diagnosis
Z state after an earlier diagnosis is related
A negationInd=true excluded this diagnosis has been excluded (use negationInd in Level 3)

Table 2: Vocabulary Domain for Reliability Codesystem: Sciphox (OID: 2.16.840.1.113883.3.7.1.8)

In tumor documentation the validation of diagnosis is also documented by specifying the (superior) way of diagnosis. This information shall also be specified through the qualifier:

Code Implementation Meaning Explanation
k clinically
z zytologically
h histologically
a autoptically
d DCO Death certificate only.
nullFlavor = OTH Other
nullFlavor = NI unknown

Table 3: Vocabulary Domain for Diagnosis procedure in tumor documentation Codesystem: (OID: 1.2.276.0.76.5.418)

Localization

targetSiteCode Lokalisation CD CWE [0..1]

Localization of diagnoses shall be specified using the model attribute targetSiteCode. For localizations given as plain text the sub-element originalText of targetSiteCode shall be used. In case no localization code is available, the XML attribute @nullFlavor shall be specified. 


<!-- structured representation of diagnosis -->
  <observation moodCode="EVN" classCode="OBS">
    ...
    <targetSiteCode nullFlavor="NI">
      <originalText>Oberhalb des rechten Knöchels</originalText>
    </targetSiteCode>
    ...
  </observation>

If a structured code is available, then model attribute targetSiteCode shall have a code sub-element with the code being specified in XML attribute @code and the coding system being specified using XML attribute @codeSystem.


Optionally the XML attribute @displayName may be used to specifiy a plain text for the code and @codeSystemName may be used for the name of the coding system. 

<!-- structured representation of diagnosis -->
  <observation moodCode="EVN" classCode="OBS">
    ...
    <targetSiteCode code="299058009" codeSystem="2.16.840.1.113883.6.96"
    codeSystemName="SNOMED CT" displayName="kleiner Finger">
      <qualifier>
        <name code="78615007" codeSystem="2.16.840.1.113883.6.96"
              codeSystemName="SNOMED CT" displayName="mit Seitenlokalisation"/>
        <value code="24028007" codeSystem="2.16.840.1.113883.6.96"
               codeSystemName="SNOMED CT" displayName="rechts"/>
      </qualifier>
    </targetSiteCode>
    ...
  </observation>

Note: The localization codes suggested by the German health Ministry (BMG) shall only be used together with diagnoses encoded in ICD 10 (German).

Additional codes for the side localization may be used in out-patient care as well as in-patient care(see 4).

In tumor documentation further codes shall be use for the side localization:


Code Implementation Meaning Explanation Common Diagnoses Tumor Diagnoses
R Right side localization right X X
L Left side localization left X X
B both side diagnosed on both sides X X
M middle line middle line zone - 1 inch left or right from middle line X
nullFlavor = NA system disease in the sense of 'not applicable' X
nullFlavor = UNK unknown X X

Table 4: Vocabulary Domain for Localization Coding System: (OID: 1.2.276.0.76.5.412)

4 DIMDI 5 Literatur: Basisdokumentation für Tumorkranke 5. Auflage 1999; Dudeck et al


The side localization is used for diagnosis documentation for common and also for tumor documentation, but with differeent value sets, which are defined as follows:

Value Set Explanation OID
Common, based on ICD-10 2.16.840.1.113883.3.7.1.7
Tumor Documentation 1.2.276.0.76.11.10

Table 5: Value Sets for Localization

Explanations

text explanation of diagnosis ST [0..1]

Any explaining text shall be represented using the XML attribute text.

A structured representation will look like this: 


<!-- structured representation of diagnosis -->
  <observation moodCode="EVN" classCode="OBS">
    <value xsi:type="CD" code="J45.0" codeSystem="1.2.276.0.76.5.311"
      displayName="Vorwiegend allergisches Asthma bronchiale">
      <originalText>Allergisches Asthma</originalText>
    </value>
    <text>Intermittierend, seit der Jugend</text>
  </observation>

Reasons for Exceptions

value Reasons for Exceptions ST [0..1]

Billling-related exceptions shall be encoded using the @value attribute of an extra Observation instance being related via an ActRelation-Ship instance to the original describing instance of Observation.

A structured representation will look like this: 

<!-- structured representation of diagnosis -->
  <observation moodCode="EVN" classCode="OBS">
    ...
    <!-- reason for exception-->
      <entryRelationship typeCode="RSON">
        <observation moodCode="EVN" classCode="OBS">
          <code nullFlavor="UNK"/>
          <value xsi:type="ED">...........</value>
        </observation>
      </entryRelationship>
    ...
  </observation>

XML attribute @typeCode shall have the value RSON (= reason) specifying an exception for billing purposes.

Using more Attributes of Observation

This section describes more model attributes of Observation that may play a role in describing diagnoses.

Attribute 'id'

id diagnosis identificator SET <II>[0..1]

The model attribute id should be used to identify the instance of a diagnosis - which is recommended for computer-based processing of diagnoses in order to refer to the clinical specification of that diagnosis.

In XML representations the XML attribute @extension shall store the diagnosis identifier while the XML attribute @root should specify the OID of the diagnosis database.

In case changes or deletions have to be communicated for this diagnosis instance, this id will provide reference.

Attribute 'classCode'

@classCode classCode <= OBS

XML attribute shall be 'OBS' - specifiying Observation as the main type of the Act instance used for documenting the diagnosis.

In XML an attribute @classCode of the element Observation represents the model attribute 'classCode' of class Observation.

Attribute 'moodCode'

@moodCode Mood Code <= EVN

Attribute @moodCode specifies how to interpret the containing Act instance.

When using an Observation to specify a diagnosis, the @moodCode shall have the value EVN, indicating that the Observation documents an earlier action.

Attribute 'negationInd'

@negationInd Negation Indicator BL [0..1]

The optional attribute @negationInd is of data type BL with values 'true' or 'false'.

Specifying a 'true' value states that the specified diagnosis has been excluded.

@negationInd is optional, the default is 'false'. If not specified, the receiving system will interpret the diagnosis as specified.

Attribute 'statusCode'

statusCode Statuscode <= completed

This attribute can be use to represent the state of the containing Act, which can be in states like e.g. "new", "active" or "cancelled". As diagnoses are considered the documentation of an action already completed, the fixed value "completed" shall be used in XML attribute @code of sub-element statusCode.


An Example

A small example shows all of the above attributes: 

  <observation classCode="OBS" moodCode="EVN" negationInd="true">
  …
  <statusCode code="completed"/>
  …
  </observation>

Representation of Diagnosis in specific Codesystems

ICD-10-GM-coded Diagnoses

The „International Statistical Classification of Diseases” (ICD) is a classification system for diseases and related health issues. It has a hierarchical structure. As the german localized version ICD-10-GM is a varient of the ICD-10 released by WHO.

Diseases are specified through alphanumeric codes. Each disease has a unique code and vice versa. The majority of codes are so-called primary diagnosis keys, i.e.they contain all information to encode a given diagnosis.

Flag de.svg Germany

ICD also provides the ability to specify secondary keys for additional information. Such secondary keys must only be used together with a primary diagnosis and are marked through asterisk (*) or exclamation (!) as additional codes .

Primary diagnosis codes either have no prefix or a cross (+).

Example.: E14.30+, H28.0* ICD-10 Code for “Diabetes mellitus with cataract“

Terms of ICD-10 Codes

ICD-10-GM will be used for encoding diagnoses in both in-patient and ambulatory care. In-patient diagnosis encoding additionally has to adhere to the German coding guidelines (§ 301, Deutsche Codierrichtlinien) and the extensions authorized by the Health Ministry (BMG).

For ambulatory care, the WHO-Table with BMG-extension is to be used.

Secondary Codes

ICD-10 GM distinguishes between primary codes and secundary codes.

Primary codes are codes without suffix or with a cross(+).

Secondary codes are those codes with an asterisk (*) or an exclam (!).

In oorder to explain their meaning we will translate some quotes of „Basiswissen Kodieren“ [Basic Encoding Knowledge by DIMDI,www.dimdi.de]

"The code for etiology (cause, origin) of a disease shall be marked with a cross (+) and its manifestation with an asterisk (*) - with the cross-code being the primary code and the asterisk-code never being used alone."

Another translated quote:

„ Asterisk codes shall only be those that are marked as explicitly permitted in ICD-10 for the asterisk-suffix."


„ Provided that the secondary code is permitted for asterisk, any other code describing the underlying disease may be used as primary code with the cross-suffix."

„... Some Codes are being marked with an exclam (!) indicating that therse are further descriptions or definitions of the severity. Such codes must not be used alone“ (without primary code).

As a result, each diagnosis must at least have a primary code and optionally secondary codes.

Each primary/secondary code is the alphanumeric string given by ICD-10 code followed by the suffix, either (†, *, !)

Side Localization

Regarding the encoding of side localizations, we translated a section from „ICD-10- Bekanntmachung des BMGS“ ("ICD-10 Communications of the German Health Ministry", 2004)

„..for the application of ICD-10-GM the following holds: When encoding the side localization, the following suffices may be used: – right: R – left: L – both sides: B ...“ [BMGS, 2004]

As a result, for each ICD-10 code, an independent side localization suffix can be appended. Note: primary code and secondary code can have different side localizations.

Example: C50.4 R Mamma Ca - right J91* L Pleural effusion in conditions classified elsewhere - left

For tumor documentation the extended table is valid.

Reliability of Diagnoses

„... When using ICD-10-GM according to § 295 SGB V (ambulatory sector) additionally the following holds: For encoding the diagnosis reliability one of the follwing suffices must be used: – for an excluded diagnosis: A – for a suspected diagnosis: V – for state (without symptoms) after the given diagnosis: Z – for a validated diagnosis: G“ [BMGS, 2004, translated by author]

As a result, ambulatory diagnoses used in the context of „Abrechnung ärztlicher Leistungen“ (billing of medical services, fixed term in the German statutory GP system acc. to german federal regulation §295 SGB V) the specification of diagnosis reliability is mandatory.

For in-patient care these suffices MUST NOT be used.

Mapping of ICD-10-coded Diagnoses into HL7 v3

Structured representations of ICD10-encoded diagnoses must support primary and secondary codes, code extensions, side localizations and reliability . The primary code represents the main disease. The secondary code extends the primary code and is either used to describe manifestations in organs ("asterisk") or the cause (etiology, e.g. which bacteria) of the main disease ("exclamation") In order to represent this dependency, an additional oberservation instance will be connected via the ActRelationship to that Observation instance containing the primary code.

So we have the following basic structure for ICD10-encoded diagnoses:

27px

Figure 2: Class Diagram of ICD-10 Diagnoses in HL7 v3

The attribute typeCode in the ActRelationship shall represent the code extension

The related Observation instance (connected via the ActRelationship) has MFST (Manifestation) as its typeCode in order to represent 'asterisk"-codes.

Exclamation-Code extensions are being represented as Observation instances connected via ActRelationships with typeCode CAUS (Cause).

The resulting XML structure of an ICD-10 encodeded diagnosis looks like this: 

<!-- Structured Representation of Diagnosis-->
   <observation moodCode="EVN" classCode="OBS">
      …
      <!-- Primary Code-->
      <value xsi:type="CD" code=" E14.30" codeSystem=" 1.2.276.0.76.5.311"/>
      <entryRelationship typeCode="MFST">
         <observation moodCode="EVN" classCode="OBS">
         …
            <!-- Secondary Code-->
            <value xsi:type="CD" code=" H28.0" codeSystem=" 1.2.276.0.76.5.311"/>
         </observation>
      </entryRelationship>
   </observation>

In this case the containing ActRelationship instance is of class entryRelationship- repesented by an element of that name.

Attribute @typeCode has MFST as a fixed value for representing an asterisk code.

value.@code ICD-Code ST [1..1] XML-Attribute @code shall store the specific ICD-10 Code.

value.@codeSystem OID of ICD-Codeset UID [1..1] XML-Attribute @codeSystem shall keep the OID of the ICD-10 Version being used. The appendix gives hints towards versions being used in practice.

value.@codeSystemName Name of ICD-10 Version ST [0..1] XML-Attribute @codeSystemName may store the Name of the used ICD-10 Version.

value.@displayName ICD-Code Text ST [0..1] XML-Attribute @displayName may store the verbose text of the ICD-Code.

OIDs and names of ICD-10 versions may be obtained from DIMDI (www.dimdi.de)

Representation of Side Localisation

value.qualifier Side Localisation CR [0..1]

The side localisation code shall be represented using the child element qualifier of the value element, as it refines the specification of that diagnosis code (as decided by HL7 DE TC meeting on 2005-09-01, minutes item 1.3.2).

An example representation looks like this: 

<!-- Structured Representation of a Diagnosis -->
   <observation moodCode="EVN" classCode="OBS">
      <code code="DX" codeSystem=""/>
      <!-- Primary code-->
      <value xsi:type="CD" code="E14.30" codeSystem="1.2.276.0.76.5.311">
         <qualifier>
            <name code="7" codeSystem="2.16.840.1.113883.3.7.1.0"/>
            <value code="L" codeSystem="2.16.840.1.113883.3.7.1.7"/>
         </qualifier>
      </value>
      <entryRelationship typeCode="CAUS">
         <observation moodCode="EVN" classCode="OBS">
            <code/>
            <!-- Sekundary code-->
            <value xsi:type="CD" code="H28.0" codeSystem="1.2.276.0.76.5.311">
               <qualifier>
                  <name code="7" codeSystem="2.16.840.1.113883.3.7.1.0"/>
                  <value code="B" codeSystem="2.16.840.1.113883.3.7.1.7"/>
               </qualifier>
            </value>
         </observation>
      </entryRelationship>
   </observation>

Child element 'name' within element 'qualifier' defines the type of qualifier.

Therefore, in order to express a qualifier for side localisation, the fixed value „7“ from code system OID 2.16.840.1.113883.3.7.1.0 shall be used: 

   <qualifier>
      <name code="7" codeSystem="2.16.840.1.113883.3.7.1.0"/>
      <value code="L" codeSystem="2.16.840.1.113883.3.7.1.7"/>
   </qualifier>
Representation of Diagnosis Reliability

value.qualifier Diagnosis Reliability CR [0..1]

The diagnosis reliability can be considered an extension to the ICD-10 code, shall be represented by the child element qualifier of the value element. 

<!-- Structured Representation of a diagnosis-->
   <observation moodCode="EVN" classCode="OBS">
      <code code="" codeSystem=""/>
      <!-- Primary code-->
      <value xsi:type="CD" code="E14.30" codeSystem="1.2.276.0.76.5.311">
         <qualifier>
            <name code="8" codeSystem="2.16.840.1.113883.3.7.1.0"/>
            <value code="G" codeSystem="2.16.840.1.113883.3.7.1.8"/>
         </qualifier>
      </value>
      <entryRelationship typeCode="CAUS">
         <observation moodCode="EVN" classCode="OBS" negationInd="true">
            <code/>
            <!-- Secondary code-->
            <value xsi:type="CD" code="H28.0" codeSystem="1.2.276.0.76.5.311">
               <qualifier>
                  <name code="8" codeSystem="2.16.840.1.113883.3.7.1.0"/>
                  <value code="A" codeSystem="2.16.840.1.113883.3.7.1.8"/>
               </qualifier>
            </value>
         </observation>
      </entryRelationship>
   </observation>

Child element 'name' within element 'qualifier' defines the type of qualifier.

Therefore, in order to express a qualifier for diagnosis reliability, the fixed value '8' from code system OID 2.16.840.1.113883.3.7.1.0 shall be used:

Child element 'value' within 'qualifier shall store the respective reliability value.

Possible values are listed in Table 2. 

   <observation classCode="OBS" moodCode="EVN">
      ...
      <value xsi:type="CD" code="A25.1" codeSystem="1.2.276.0.76.5.311" codeSystemName="icd10gm2006">
         <qualifier>
            <name code="8" codeSystem="2.16.840.1.113883.3.7.1.0"/>
            <value code="G" codeSystem="2.16.840.1.113883.3.7.1.8"/>
         </qualifier>
      </value>
   </observation>

When representing an EXCLUDED diagnosis the attribute @negationInd shall be specified as „true“.

Specifying a Diagnosis using a Thesaurus Index

One more way of specifying a diagnosis is by using an index referring to an entry in a medical thesaurus.


Example: Mapping an Alpha-ID-coded Diagnosis

Flag de.svg Germany

As an example, the diagnostic thesaurus „Alphabetische Verzeichnis zur ICD-10 GM“ (alphabetic directory of ICD-10 GM) is being used in Germany.

This directory allows to locate a verbose description of ICD-10 terms and to find the corresponding ICD-10 GM code.

The so-called Alpha-ID has been developed to process entries of that alphabetic directory.

It is an identification number for each textual entry in the "alphabetic directory".

In order to find this alpha-ID, a mapping file has been provided by DIMDI (www.dimdi.de).

The Alpha-ID is needed because in medical documentation, the descriptions of diagnoses need to be more differentiated than what ICD-10 codes actually can express.

Using the alpha-ID allows for a much finer granularity of diagnosis descriptions.[DIMDI,Alpha_Id].

As an example the ICD-10 Code “A01.0 Typhus caused by Salmonella typhi“ encodes multiple diagnoses such as „liver typhus“, „lung typhus“ and many more.

By using the Alpha-Id it is possible to specify the specific type of typhus, like e.g. „liver typhus“ as„I18721“ and „lung typhus“ as „I21312“. 

  1;I22457;A01.0;;;Darmtyphus
  1;I75303;A01.0;;;Eberth-Krankheit
  1;I71406;A01.0;;;Enteritisches Fieber
  1;I22466;A01.0;;;Enterotyphus
  1;I22467;A01.0;;;Febris enterica
  1;I17704;A01.0;;;Gallenblasentyphus
  1;I71415;A01.0;;;Gastroenteritisches Fieber
  0;I78350;A01.0;;;Gastrointestinale Perforation bei Typhus
  1;I17794;A01.0;;;Gehirntyphus
  1;I21313;A01.0;;;Hauttyphus
  1;I22455;A01.0;;;Ileotyphus
  1;I94981;A01.0;;;Infektion durch Bacterium typhosum
  1;I73671;A01.0;;;Infektion durch Eberthella typhosa
  1;I22458;A01.0;;;Infektion durch Salmonella typhi
  1;I18721;A01.0;;;Lebertyphus
  1;I21312;A01.0;;;Lungentyphus
  1;I96251;A01.0;;;Lymphadenitis mesenterialis durch Salmonella typhi
  1;I66509;A01.0;;;Posttyphoider Abszess
  1;I22456;A01.0;;;Status typhoides
  1;I22463;A01.0;;;Typhoenteritis
  1;I71447;A01.0;;;Typhogastrisches Fieber
  1;I22462;A01.0;;;Typhoides Fieber
  1;I31416;A01.0;;;Typhomanie
  1;I22464;A01.0;;;Typhoperitonitis
  1;I22454;A01.0;;;Typhus
  1;I22461;A01.0;;;Typhus abdominalis
  1;I73926;A01.0;;;Typhusinfektion

Figure 3: Excerpt from mapping file „icd10gm2009_alphaid_edv_ascii20081006.txt“


Figure 4 shows an excerpt of the metafile which defines the fields of the mapping file for the Alpha-Id.

Each record consists of six fields, each being separated by a semicolon.

The fields in each record contain the following data: 

  Field 1: Validity (0-not valid, 1-valid)
  Field 2: Stable Identification with prefix I or T ("Alpha-Identifikationsnummer")
  Field 3: Primary key (with cross)
  Field 4: Asterisk key (with asterisk)
  Field 5: Additional key (with exclamation)
  Field 6: Related text

Figure 4: Excerpt from Alpha-ID metafile „icd10gm_alphaid_edv_ascii_liesmich.txt“


A structured representation of a thesaurus uses the @value attribute of class Observation and an example instance lloks like this: 

   <observation moodCode="EVN" classCode="OBS">
   …
   <value xsi:type="CD" code="I2173" codeSystem="1.2.276.0.76.5.309" codeSystemName="alphaid2006"/>
   ...
   </observation>

value.@code Alpha-Id ST [1..1] XML-Attribute @code stores the index referring to an enty in the „Alphabetisches Verzeichnis“

value.@codeSystem OID ofAlpha-ID UID [1..1] XML-Attribute @codeSystem stores the OID of the Alpha-ID Version being used.

value.@displayName Alpha-Id Text ST [0..1] XML-Attribute @displayName may be used to display a text related to the current Alpha-Id

value.@codeSystemName Name of Alpha-ID Version ST [0..1] XML-Attribut @codeSystemName represents the Name of the coding system, in our case alphaid2006.

OID and name of ICD-10 Version can be obtained from DIMDI (www.dimdi.de)

Diagnosis Specification using Identifiers in a Nomenclature

One way of specififying a diagnosis is to use the code representing a diagnostic term in some medical nomenclature.

A well-known nomenclature in medicine is SNOMED-CT ("systematic nomenclature of medicine - clinical terms")

Compared to ICD-10 it has more concepts for diagnoses and mostly does not classify.

In general using a term of a nomenclature often preserves more information than using a term of a classification.

Classification is selecting a common representation for a set of concepts that are (under some aspect) considered similar.

As a result, classification reduces information, which is demonstrated by the following examples

I.e. as a part of clinical documentation of diagnosis the encoding using alpha-id or some identifier in a nomenclature would be preferred over using a classification like e.g. ICD-10.

The example shows concepts all being represented through the same ICD-10 code Q92.8 for 'Other specified trisomies and partial trisomies of autosomes'.

A simple comparison of codes from nomenclatures gives an example of missing clarity and precision of the ICD-10 classification.

Diagnosis ICD-10 Code Alpha-ID Snomed CT ID MACS
Imbalanced Insertion Q92.8 I87548 254262003 M002405-D62839-58
Trisomy 22 Q92.8 I81282 205655003 M001897-D55549-58
Trisomy 20 Q92.8 I81283 53346000 M002406-D55530-58
Partial Trisomy a.n.k. Q92.8 I81284 133849008 M001D1C-C78409-58

Table 6: Diagnoses in different coding systems


Precoordinated and Postcoordinated Concepts of a Nomenclature

For specifiying a diagnosis using a terminology there are two fundamental approaches:

The pre-coordinated approach selects a fixed term among a comprehensive list with representations for all possible concepts.

The list of all pre-coordinated terms limits the set of concepts which can be represented.

The post-coordinated approach constructs each term out of (more or less independently) encoded aspects of the concept to be represented.

The resulting term is the combination of the encoded aspects of the given concept.

ICD-10 is a good example of a pre-coordinated terminology, as it lists all the terms for the concepts it can represent.

The cross-asterisk extension to ICD-10 is an example of post-coordination.

More info can be found under the Terminfo project [Terminfo] of HL7 International.

Diagnosis by Thesaurus Index or Term within a Nomenclature

A term in a nomenclature is specified through the @value attribute of class Observation.

An example (SNOMED CT) of the structured representation looks like this: 

   <observation moodCode="EVN" classCode="OBS">
   ...
   <value 
      xsi:type="CD" code="314888007" 
      codeSystem="2.16.840.1.113883.6.96"
      codeSystemName="SNOMED CT"
      displayName="Typ-II-Diabetes with diabetic cataract"/>
   ...
   </observation>
Attribute value.@code Index or Term in Nomenclature

CD CWE [1..1] The XML attribute @code keeps the index referring to an entry in a thesaurus or nomenclature.

Attribute value.@codeSystem OID of Nomenclature

UID [1..1] The XML attribute @codeSystem stores the OID of the thesaurus or nomenclature.

Attribute value.@displayName Text

ST [0..1] Through the XML attribute @displayName a plain text related to the index can be given.

Attribute value.@codeSystemName Name of Nomenclature

[0..1] The XML attribut @codeSystemName describes the name of the thesausrus or nomenclature.

Representation of Cancer Diagnosis

Introduction

In this chapter, diagnostic aspects of documentation of tumor diseases will be described. Different aspects of diagnostical descriptions of tumor diseases are described by ICD-O (Oncology) and by further classifications to document the expansion (tumor spread) or diseases stage, respectively, the latter one mostly being classified by the TNM-System.

Especially for hemato oncological diseases (Leukemias and Lymphomas), other systems (e.g. Ann-Arbor-Classification) are used. TNM-System discribes:

  • Expansion of primary tumor (extent or, spread in distant organs repectively)
  • Affection of lymph nodes in lymph flow area
  • Existence of distant metastases.

For non-TNM–-classifiable diseases or in addition to the TNM-System there are a number of further classification systems:

  • Ann Arbor
  • Rai
  • Binet
  • CML-Phasen
  • FAB
  • Durie and Salmon
  • Gleason-Score

Discriptions can be found here: http://www.med.uni-giessen.de/akkk/gtds/grafisch/doku/bd5f.htm http://www.tumorzentren.de/tl_files/dokumente/adt_basis.pdf

This list probably will be always incomplete because of the medical progress.

ICD-O

Third Edition of ICD-O [DIMDI, WHO] is the topical one. ICD-O consists of two axes, Topography- and Morphology-Axis. In ICD-O, tumor can be classified by

  • Site
  • Tissue Structure (Histology)
  • Biological behaviour (Dignity)
  • Tissue grading (mostly in two or four stages)

In this case, tissue structure and tissue grading is redundant. Precisely: The first four digits of morphology-code describe tissue-type. The fifth one describes biological behaviour (dignity-code):

  • /0 = benign
  • /1 = neoplasm with uncertain or unknown behaviour
  • /2 = Cancer in situ
  • /3 = malignant, primary tumor
  • /6 = malignant, metastasis (not used in tumor documentation)
  • /9 = malignant, uncertain wether primary tumor or a metastatic

The sixth digit describes grading, differentiation or phenotype (Histology/Pathology):

  • 1 = Grade I, well differentiated (Low grade)
  • 2 = Grade II, moderately differentiated (Intermediate grade)
  • 3 = Grade III, poorly differentiated (High grade)
  • 4 = Grade IV, undifferentiated (High grade)
  • 9 = Grade IX, grade cannot be assessed

For Leukemias and Lymphomas, the sixth digit signifies the immunophenotype

  • 5 = T-Cell
  • 6 = B-Cell, Pre-B-Cell, B-Ancestor-Cell
  • 7 = Null-Cell, Not-T-Cell-Not-B-Cell
  • 8 = NK-Cell, Natural Killer Cell
  • 9 = Determination of Cell Type was not accomplished, not specified or not applicable

TNM System describes

  • Expansion of primary tumor (extent repectivly spread in distant organs)
  • Affection of lymph nodes in lymph flow area
  • Exisistence of distant metastasis

For the topography axis, there exists an (hierarchical) enlargement, the ‘localisation key’ (Wagner, G. (HRSG.): Tumorlokalisationsschlüssel, 5. Auflage, Springer Verlag, Berlin, Heidelberg, New York, Tokyo 1993), which can supply at some positions clinical relevant differentiation. The morphology axis is composed of a four-digit code for tissue basic structure, a characteristic number for dignity and an additional grading item. The key itself does not contain all possible combinations of histology and dignity, but points out those ones, for whome exist special discriptions. Vice versa not all combinations of basic structure and dignity are possible (so there is no ‘benign leukemia’). Not either there is a grading system available for all kinds of tumor. For some ones, additional information (for Example ‘Cell-line’) is used at the corresponding position.

Tumor Localization

For Tumor-Coding first of all, the site is important. It will be classified by the Topography -Axis of ICD-O. Topographical -Codes of ICD-10 are based on chapter II (Neoplasm –C 00 – C 97) of ICD-10. However, some of the topographical Codes of ICD-10 (Codes) are not used, because their content is discribed by histology- and digit-Codes of ICD-O. (e.g. Differentiation in situ/ infiltrated, melanoma vs. scin cancer).

Tumor Histology and Dignity

Furthermore, in ICD-O, tumor morphology i.e. tissue structure (histology) and biological behavior (dignity) is discribed by special Codes. Tumor histology is coded by a four-digit number, which is assumed of the morphology-axis of Standardized Nomenclature of Patholoy (SNOP). Dignity-Code is attendant on morphology-Code, seperated by /. Examples:

  • 8060/0 squamous epithelium - papillomatose
  • 8070/2 squamous epithelium – cancer in situ undifferentiated
  • 8070/3 squamous epithelium – cancer undifferentiated
  • 8070/6 squamous epithelium – cancer metastasis undifferentiated

Tumor Grading

Grading is derived from the comparison of primary tissue with the neoplasm of this tissue. There are five grading-degrees (s.o.) and further three degrees for Malignant Lymphoma. Registration of tumor grading is also provided in TNM.

Qualifier of Tumor Formula

ICD-O –Codes can be specified by the following qualifier:

Here ICD-O provides additionally the following codes for Lymphoma, which specify the Cell line: B-Cell, T-Cell, Null-Cell Lymphoma. ICD-O uses the Codes 1 – 9. A detailled System is discribed in Chapter 9 under 9.5.2 and 9.53.

Example

GRAPHIC IS MISSING

DisplayName is only available in correlation to qualifiers. According to ICD-O-3 formation rule there are much more discriptions possible as ICD-Catalog proposes.


TNM Classification

The TNM classification describes the expansion (spread) of the tumor , i.e. stadium and prognosis of the disease.

As a special feature, the TNM classification uses the same notation for all tumors but supports different interpretations for different entities.

As an example, a T3 for mamma carcinoma has a different interpretation than the stomach carcinoma.

The current edition is 7th which is valid since January 2010, which is a reason why many TNM-6- codes may still be in use. Therefore all TNM-codes should have a version identifier, because non translatable differences are in the different editions.

A simple overview can be found in http://de.wikipedia.org/wiki/TNM.


The T category will be used for the expansion of the primary tumor, where the stages T0, Tis, T1-T4 und TX are being used, the "higher" the number, the more progress is being diagnosed and the more adverse the prognosis.

T0 stands for "no primary tumor found" (e.g. because being eradicated by therapy) Tis stands for a very early (non-infiltrating) stage tumor (Tumor in situ) and TX stands for a diagnosis which can not judge the stage because of missing data

For some tumors subcategories like e.g. T2a, T2b have been defined.


The N-category classifies the affection of lymphatic nodes - usingN0, N1-N3, NX, where N0 means "no lymphatic node affected".

For some tumors, this exclusion ("N0") requires the examination of a minimum amount of nodes.

The higher the N category the more severe is the lymphatic node affection.

If no sufficient data is available NX is being diagnosed.


The M category describes the existence of distant metastases, with the vallues of M0 (no metastases detectable), M1 (metastases detectable) and MX (insufficient data).


The TNM can be used according to clinical criteria (preoperative, cTNM) and according to the pathology findings (pTNM).

For many patients one single diagnoss will be made, either a cTNM or a pTNM, such that this type of finding must be distinguished.

This preoperative ("c" or no prefix) / pathology ("p") attribute can be captured independently for each of the T N M categories.

Therefore the typically used pTNM often meanes pTpNcM, because the spread of a timur can best be diagnosed through surgery while lymphatic spread only by pathology.

The prefix "r" describes remaining tumors (after non-disease intervals) and a prefix "y" if the classification was assessed after systemic or radiation treatment (ycTNM, ypTNM etc.).

For multiple Primary tumors the suffix "m" (or the number of tumors) will be put after the T-category value(T2(m), T2(5)).


Therefore a complete TNM formula looks like this:

There are voluntary components e.g. the certainty-Faktor (C-Factor)

Other components require pathology lab examination (L-, V- or Pn-Category)

  • y-Symbol (y or empty, disgnosis after systematic or xray treatment)
  • r-Symbol (r or empty, remainder)
  • p/c/a-Symbol for pT-category (clinical or pathological)
  • T-Category
  • (m) for multiple localizations or number of tumors
  • C-Factor for T-Category (certainty)
  • L-Category
  • V-Category
  • Pn-Category
  • p/c/a-Symbol for pN-Category (clinical or pathological)
  • N-Category
  • C-Factor for N-Category (certainty)
  • p/c/a-Symbol für pM-Category
  • M-Category
  • C-Factor for M-Category (certainty)
  • S-Kategorie (serological values, only for testicle tumors)
  • UICC-Stadium (Grading via UICC 0 and I-IV together with

letter A, B and C for further classification).

For some tumors further modifiers are being documented as a suffix (mostly in parenthenses) like e.g. (sn), (mol-),(mol+).

In addition, the TNM supplement introduces innovative or "under test" extensions, which raises doubts whether ta full control of TNM entries.

Typical T-Categories (without pre-/suffices) are being listed in chapter "Sites"

Typical N-Categories (without pre-/suffices) are being listed in chapter "Nodes".

Typical M-Categories (without pre-/suffices) are being listed in chapter "Metastases".

9 Reference: DKFZ

Qualifiers of the Tumor Formula

Despite values for T,N and M the TNM formula may also contain various qualifiers. The following table gives an overview which qualifiers can be used for which information and where they are being used. This is case-sensitive!

  • a Autoptical
  • c Clinical
  • C C-Factor (certainty)
  • G histopathological Grading
  • L Lymphatic vessel invasion
  • m multiple Tumors
  • M distant metastases
  • N Regional lymphatic node metastases
  • p pathological
  • Pn perineural Invasion
  • r Rezidiv tumor
  • R Residual tumor after treatment
  • sn Sentinel-Lymphatic nodes
  • Stage Anatomic Stage-Grouping
  • T Expansion (spreading) of Primary tumor
  • V Venous invasion
  • y Classification after initial multi-modal Therapy

Ann Arbor Classification

For lymphoma the TNM-classification does not make sense and therefore theso-called Ann-Arbor classification will be applied.

In this system, the stages I-IV are being distinguished, with an additional suffix letter

  • A meaning "no general symptoms"
  • B "with general symptoms"
  • E "extra-lymphatic organ affected"
  • S "spleen affected"

As with TNM, the Ann-Arbor classification distinguishes between clinical (cS) and pathological (pS) grading.

According to Durie & Salmon tere are gradings from I to III or the grades according to SWOG from 1-4 for the "Multiple Myeloma".

FIGO Stages

FIGO stages ignificantly overlap with the TNM classification, especially on the T-axis.

Therefore no details are being given here.

Gleason Score

The so-called Gleason-Score serves to classify the prostate carcinoma. The total numeric value is the sum of two indicators for • loss of differentiation (1-5) • growth pattern (1-5)

Resulting values range from 2 to 10 (also see Scores & Assessment DSTU).

Furthermore there is a more recent Gleason classification (according to Dhom, Müller and Helpap [Helpap 2002, Helpap2007]), which also requires to specify the procedure (esp. the two degrees) being used.

Papanikolaou

The so-called Pap-Test [Pap] is based on colored cell samples from the cervix and is used as an early indocator for cervical cancers.

WHO Grading

The so-called WHO Grading serves as an individual progonosis on the one hand and also is an indicator towards further treatment on the other hand.

Tumors of WHO Grade I and II in most cases can be treated by surgery alone, while tumors with WHO Grading III and IV normally need additional treatment by radiation or chemotherapie after surgery.

The grading looks like this:

Code Codename Meaning
I benign,slow growth of tumor, very good prognosis
II still benign, slow growth of tumor,tendency to recur
III malignant,actively producing abnormal cells,tends to recur
IV very malignant,fast growth,needs systemic therapy, bad prognosis

Table 9: WHO Grading (OID 1.2.276.0.76.5.394)

The fourth edition of the "World Health Organization (WHO) Classification of tumours of the central nervous system" (2007) lists all relevant tumor entities.

Also see "Brain Tumor Basics" (http://www.abta.org/sitefiles/sitepages/524309b806778d4f7b79044d97f324ea.pdf)

Conclusion

The following data of tumors can be represented by these respective classifications (through values and/or modifiers)


Concept Classification
Tumor localisation ICD-O
Morphology + dignity ICD-O
Tissue differentiation ICD-O ICD-O/TNM
type of stage codes (c,p,r,y) TNM/Ann-Arbor
T Code + C Factor, multiplicity TNM
M Code + C Factor, multiplicity TNM
N Code + C Factor, multiplicity TNM
Residual Tumor TNM
stage grouping TNM/Ann-Arbor/Durie&Salmon/SWOG

Cancer Diagnosis in HL7 V3

Representing Cancer Diagnoses in HL7

Tumor diagnoses shall be represented in HL7 V3 according to the following schema: A centralised instance of Observation shall specify the ICD-O code in the 'value' model-attribute with Dignity and (differentiation) grading in its 'qualifier' sub-element.

Further details shall be represented in more Observation-instances being connected via supporting ActRelationShip instances with typeCode:=SPRT .

The CertaintyFactor shall be in the 'qualifier' sub-element of the model-attribute 'value' but only for those Observation instances which represent a T-, N- or M-Classification.

Multiplicity shall be in one more Observation instance related (supporting ActRelationShip) to that Observation instance representing the T-Classifier.

Tree View of HL7-based Representation of Cancer Diagnosis

 +- ICD-O (Dignity, Grading)
 +- T-Category (c, p, r, y)
 | +- Multiplicity
 +- N-Category (c, p, sn)
 | +- Number of nodes examined and marked positive
 +- M-Category (c, p)
 +- Residual Tumor
 +- Grading
 +- Cell Type
 +- Lymphatic Invasion
 +- Venous Invasion
 +- Perineural Invasion
 +- Staging
 +- Ann-Arbor
 +- Gleason-Score
Code Codename Class / Path Representation (Observation or Qualifier)
DF Differenzierungsgrad Observation (ICD-O) qualifier.@name
DN Dignität Observation (ICD-O) qualifier.@name
T T support-Observation Observation/value.@code
M M support-Observation Observation/value.@code
N N support-Observation Observation/value.@code
MP Multiplicity support-Observation

(T)-support-Observation

Observation/value.@code
CF Certainty Factor support-Observation(T or N or M) qualifier.@name
RS Residual tumor support-Observation Observation/value.@code
GR Grading support-Observation Observation/value.@code
LI Lymphatic invasion support-Observation Observation/value.@code
VI Venous invasion support-Observation Observation/value.@code
SG Staging support-Observation Observation/value.@code
AA Ann-Arbor-Classification support-Observation Observation/value.@code

Table 10: Codes for Tumor Diagnoses (OID 1.2.276.0.76.5.334)

Example

<observation classCode="OBS" moodCode="EVN">
  ...
  <value xsi:type="CD" code="8070" codeSystem="2.16.840.1.113883.6.43.1"
    displayName="Plattenepithelkarzinom"
    codeSystemName="icd-o-3">
    <qualifier>
      <!-- Dignity -->
      <name code="335" codeSystem="2.16.840.1.113883.3.7.1.0"/>
      <value code="0" codeSystem="1.2.276.0.76.5.335"/>
    </qualifier>
    <qualifier>
      <!-- Differentiation/Grading -->
      <name code="336" codeSystem="2.16.840.1.113883.3.7.1.0"/>
      <value code="1" codeSystem="1.2.276.0.76.5.336"/>
    </qualifier>
  </value>
  <!-- Tumor formula -->
  <entryRelationship typeCode="SPRT">
    <observation moodCode="EVN" classCode="OBS">
      <!-- T-Code -->
      <value xsi:type="CD" code="T1" codeSystem="2.16.840.1.113883.15.8" codeSystemName=" tnm5"/>
        <qualifier>
          <name code="341" codeSystem="2.16.840.1.113883.3.7.1.0"/>
          <value code="C2" codeSystem="1.2.276.0.76.5.341"/>
        </qualifier>
      </value>
    </observation>
  </entryRelationship>
  <entryRelationship typeCode="SPRT">
    <observation moodCode="EVN" classCode="OBS">
    <!-- N-Code -->
      <value xsi:type="CD" code="N2" codeSystem="2.16.840.1.113883.15.8" codeSystemName="tnm5"/>
      </value>
    </observation>
  </entryRelationship>
  <entryRelationship typeCode="SPRT">
    <observation moodCode="EVN" classCode="OBS">
    <!-- M-Code -->
      <value xsi:type="CD" code="M0" displayName="Fernmetastasen nicht vorhanden"
        codeSystem="2.16.840.1.113883.15.8" codeSystemName="tnm5"/>
      </value>
    </observation>
  </entryRelationship>
</observation>

Representation for specific Use Cases

Introduction

The following sections present examples for structured diagnosis representations in selected applications.

GP/Ambulatory Billing Diagnosis (Germany)

This example shows a so-called "KVDT Record" according to §295 (German Federal Code SGB V) with a diagnosis to be represented through HL7 version 3.

Diagnosis fields in the current KVDT record:

FK Usage Field Name Field Type Conditions Explanations
6001 n ICD-Code m 
Rule 486
Rule 488
Rule 489
Rule 490
Rule 492
see chapter 7
6003 1 Diagnosis Reliability m Rule 484 see chapter 7
6004 1 Side Localization k see chapter 7
6006 n Diagnosis Explanations k see chapter 7
6008 n Diagnosis Exception Case m Rule 491
3673 n Continued Diagnosis (ICD-Code) m 
Rule 486
Rule 488
Rule 489
Rule 490
Rule 492
3674 1 Diagnosis Reliability/

Continued Diagnosis

m
3675 1 Side Localization

Continued Diagnosis

k
3676 n Diagnosis Explanation

Continued Diagnosis

k
3677 n Diagnosis Exception Case

Continued Diagnosis

m Regel 491

Table 11: GP/Ambulatory Billing Diagnoses (Germany) ref 10,11

Multiple ICD-10 codes may be specified - without a (mandatory) check of its medical validity but with at least one primary ICD-10 code being required.

With each code, a ide localization, a diagnosis reliability, diagnosis explanations and exception cases may be specified.

Control code 6001 indicates a (current) billing diagnosis, while control code 3673 indicates a continued diagnosis.

  • 10 FK: Field (control) code
  • 11 m = MANDATORY, k = OPTIONAL

Example in HL7-V3:

<!-- Diagnose (Abrechnungsdiagnose) 6001-->
<!-- :A17.0+;G01*;;Tuberkulöse Meningitis Gesichert Rechts-->
<!-- Diagnose 1***************************************************************-->
…
<observation classCode="OBS" moodCode="EVN">
  <!-- Code für Abbrechungsdiagnose 6001-->
  <code code="XXX_DX" codeSystem="2.16.840.1.113883.5.4"/>
  <!-- Diagnoseerläuterung 6006**********************************************-->
  <text/>
  <!-- Primärcode 6001*******************************************************-->
  <value xsi:type="CD" code="A17.0" codeSystem="1.2.276.0.76.5.311"
    codeSystemName="icd10gm2006">
    <!-- Diagnosesicherheit 6003-->
    <qualifier>
      <name code="DSH" codeSystem="111.111.1.1.1"/>
      <value code="G" codeSystem="1.2.276.0.76.3.1.1.5.1.21"/>
    </qualifier>
    <!-- Seitenlokalisation 6004-->
    <qualifier>
      <name code="SL" codeSystem="111.111.1.1.1"/>
      <value code="R" codeSystem="1.2.276.0.76.3.1.1.5.1.22"/>
    </qualifier>
  </value>
  <!-- Ausnahmetatbestand zu Primärcode**************************************-->
  <entryRelationship typeCode="RSON">
    <observation classCode="OBS" moodCode="EVN">
      <code nullFlavor="NI"/>
      <value xsi:type="ST">…</value>
    </observation>
  </entryRelationship>
  <entryRelationship typeCode="MFST">
  <!-- Sekundärcode 6001*************************************************-->
    <observation classCode="OBS" moodCode="EVN">
      <code code="XXX_DX" codeSystem="2.16.840.1.113883.5.4"/>
      <!-- Diagnoseerläuterung 6006**************************************-->
      <text>Diagnoseerläuterung</text>
      <value xsi:type="CD" code="G01" codeSystem="1.2.276.0.76.5.311" codeSystemName="icd10gm2006">
        <!-- Diagnosesicherheit 6003-->
        <qualifier>
          <name code="DSH" codeSystem="2.16.840.1.113883.3.7.1.0"/>
          <value code="G" codeSystem="1.2.276.0.76.3.1.1.5.1.21"/>
        </qualifier>
        <!-- Seitenlokalisation 6004-->
        <qualifier>
          <name code="SL" codeSystem="2.16.840.1.113883.3.7.1.0"/>
          <value code="R" codeSystem="1.2.276.0.76.3.1.1.5.1.22"/>
        </qualifier>
      </value>
      <!-- Ausnahmebegründung zum Sekundärcode 6008***********************-->
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <code nullFlavor="NI"/>
          <value xsi:type="ST">…</value>
        </observation>
      </entryRelationship>
    </observation>
  </entryRelationship>
</observation>

Diagnosis in the Referral Letter / Medical Documentation

The Implementation Guideline „Arztbrief“ (www.hl7.de) as well as related documents lists various examples of how to represent diagnoses via HL7 V3/CDA Release 2 (see [CDAr2Arztbrief]).

Terminology

Introduction

This chapter separates codes in use from normative specifications, in order to allow updates to such codes without having to rewrite the normative part. Therefore this chapter is just informative. Current codes have to be requested.

Due to pending third-party copy rights regarding some of the the following tables, the textual descriptions may not be given here such that the respective fields remain empty.

Overview of Value Sets

Value Sets OID Short Term German English
Tumors 1.2.276.0.76.11.1 uicctumor ValueSet für Tumore in der Tumordokumentation ValueSet for tumors in the cancer documentation
Nodes 1.2.276.0.76.11.2 uiccodes ValueSet für Knoten in der Tumordokumentation ValueSet for nodes in the cancer documentation
Metastases 1.2.276.0.76.11.3 uiccmetastasen ValueSet für Metastasen in der Tumordokumentation ValueSet for metastases in the cancer documentation
ResidualTumor 1.2.276.0.76.11.4 uiccresidualtumor ValueSet für Residualtumor in der Tumordokumentation ValueSet for residual tumor in the cancer documentation
Stage Classification 1.2.276.0.76.11.5 uiccstages ValueSet für die Stadiengruppier ung in der Tumordokumentation ValueSet for stages in the cancer documentation
Venous Invasion 1.2.276.0.76.11.6 uiccveneninvasion ValueSet für die Veneninvasion in der Tumordokumentation ValueSet for venous invasion in the cancer documentation
Lymphatic Invasion 1.2.276.0.76.11.7 uicclymphsysteminvasion ValueSet für die Lymphsysteminvasion in der Tumordokumentation ValueSet for the lymphatic system invasion in the cancer documentation
Perineural Invasion 1.2.276.0.76.11.8 uiccneuralscheideninvasion ValueSet für die Neuralscheideninvasion in der Tumordokumentation ValueSet for the perineural invasion in the cancer documentation
TNM Qualifier 1.2.276.0.76.11.9 uicctnmqualifier ValueSet für die TNM-Qualifier in der Tumordokumentation ValueSet for tnm qualifier in the cancer documentation
TNM Localisation for Tumor Documentation 1.2.276.0.76.11.10 uicclocalisation ValueSet für die TNM-Seitenlokalisation in der Tumordokumentation ValueSet for tnm localisation in the cancer documentation

Table 12: Value Sets

UICC 5. Edition (OID 2.16.840.1.113883.15.8) UICC 6. Edition (OID 2.16.840.1.113883.15.7) UICC 7. Edition (OID 2.16.840.1.113883.15.6)


Overview of Coding Schemata

Vocabulary Domain/Coding System OID Short Term
ICD10GM
ICD­10 GM Version 2012 1.2.276.0.76.5.409 icd10gm2012
ICD­10 GM Version 2011 1.2.276.0.76.5.388 icd10gm2011
ICD­10 GM Version 2010 1.2.276.0.76.5.384 icd10gm2010
ICD­10 GM Version 2009 1.2.276.0.76.5.356 icd10gm2009
ICD­10 GM Version 2008 1.2.276.0.76.5.330 icd10gm2008
ICD­10 GM Version 2007 1.2.276.0.76.5.318 icd10gm2007
ICD­10 GM Version 2006 1.2.276.0.76.5.311 icd10gm2006
ICD­O
ICD­O­3 2.16.840.1.113883.6.43.1 icd­o­3
ICD­O­DA­1978 n.a.
ICD­O­DA­2002 n.a.
TNM
C­Faktor 1.2.276.0.76.5.341 c­faktor­tumor
TNM 5. Edition 2.16.840.1.113883.15.8 tnm5
TNM 6. Edition 2.16.840.1.113883.15.7 tnm6
TNM 7. Edition 2.16.840.1.113883.15.6 tnm7
Dignity 1.2.276.0.76.5.335 dignitaet­tumor
Cell­ Type 1.2.276.0.76.5.???
Validity R­Classification 1.2.276.0.76.5.???
Existence of Residual Tumor 1.2.276.0.76.5.???
Tumor Diagnoses 1.2.276.0.76.5.334 tumordiagnosen
Grading 1.2.276.0.76.5.336 grading_tumor
­Localisation of Metastases 1.2.276.0.76.5.401
Scores
Gleason­Score
Gleason­Score: Loss of Differentiation 1.2.276.0.76.5.402
Gleason­Score: Growth Pattern 1.2.276.0.76.5.403
Gleason­Score: Grading 1.2.276.0.76.5.404
Ann­Arbor 1.2.276.0.76.5.405
Papanikolaou: Grading 1.2.276.0.76.5.406
Alpha­ID
Alpha­ID 2012 1.2.276.0.76.5.408 alphaid2012
Alpha­ID 2011 1.2.276.0.76.5.387 alphaid2011
Alpha­ID 2010 1.2.276.0.76.5.383 alphaid2010
Alpha­ID 2009 1.2.276.0.76.5.355 alphaid2009
Alpha­ID 2008 1.2.276.0.76.5.329 alphaid2008
Alpha­ID 2007 1.2.276.0.76.5.316 alphaid2007
Alpha­ID 2006 1.2.276.0.76.5.309 alphaid2006
MeSH
MeSH 2.16.840.1.113883.6.177.5 MSHGER
Snomed CT
SNOMED CT 2.16.840.1.113883.6.96 SNOMED CT
ID Macs
ID Macs 1.2.276.0.76.5.305 id_macs
Typing Diagnosis 1.2.276.0.76.5.342

Table 13: Coding Schemata

Diagnosis Types In Germany

The following codes are being used for typing of diagnoses. This table is a pragmatic collection of the current state-of-the-art in german systems. An international classification is not available at this time.

Code Meaning
DX Diagnosis, not specified any further
RFFDX Referral Diagnosis
ENTDX Entry Diagnosis
TRFDX Transfer Diagnosis
ADMDX Admittance Diagnosis
CDDX Clinical Department’s Diagnosis
CDXDX Clinical Department’s extra Diagnosis
CDTDX Clinical Department’s Treatment Diagnosis
CDDISDX Clinical Department’s Discharge Diagnosis
CDADMDX Clinical Department’s Admittance Diagnosis
SUCCDX Successive Diagnosis (with continuing sick leave)
DISDX Discharge Diagnosis
TDX Transfer Diagnosis
PERMDX Permanent Diagnosis
APERMDX Anamnestic Permanent Diagnosis
BPERMDX Treatment-related Permanent Diagnosis
EMERDX Emergency-related Diagnosis
REIMDX Reimbursement Diagnosis
POSTOPDX Post-operative Diagnosis
PREOPDX Pre-operative Diagnosis
ADR UAW ­Observed Unwanted Side Effects
ADRPD UAW Main Disease
ADRCCD UAW Side Disease  
IFSGDX If–G ­Diagnoses
IFSGSUSPDX If–G ­Suspicious Diagnoses
IFSGDD If–G ­Differential Diagnoses
COD Cause of Death (fatal disease)
CCCOND Accompanying Diseases
EXTCS External Cause
NEO Neoblasts
UAE Unwanted Medication Event
UAW Unwanted Medication Effect12
CAREDX Care Diagnosis
SYMDX Symptom
OTHDX Miscellaneous Diagnosis

Table 14: Diagnosis Types (OID 1.2.276.0.76.5.342)

ICD-O Codes

Dignity

Dignity refers to a tumor property related to their biological behavior in the body. 13

Meaning Code
0 benign
1 Neoplasm with uncertain or unknown behaviour
2 Carcinoma in situ
3 malign, Primary Tumor
6 malign, Metastasis
9 malign, not differentiated between Primary Tumor or Metastasis

Table 15: Dignity Codes (OID 1.2.276.0.76.5.335)

12 In this case, a cause has to be documented along with the diagnosis – but that is not covered in this implementation guide. It also has to be clarified whether such diagnosis is equal to “suspicious for”. 13 DIMDI www.dimdi.de ICD10GM, ICDO3


Grade of Differentiation/Grading

The following table lists possible gradings. The entity column lists to what tumor entities these grades apply. ref.14

Code Description German Entity
0 Primary acquired melanosis Malignant Melanoma of Conjunctiva
1 well differentiated Gut differenziert all but Prostata, Malignant Melanoma of Conjunctiva
Well differentiated (slight anaplasia) (Gleason 2­4) Prostata
Malignant melanoma arising from a naevus Malignant Melanoma of Conjunctiva
2 moderately differentiated Mäßig differenziert all but Prostata, Malignant Melanoma of Conjunctiva
Moderately differentiated (moderate anaplasia) (Gleason 5–6) Prostata
Malignant melanoma arising from primary acquired melanosis Malignant Melanoma of Conjunctiva
3 poorly differentiated Schlecht differenziert all but Prostata, Penis, Kidney, Renal Pelvis and Ureter, Urinary Bladder, Urethra, Malignant Melanoma of Conjunctiva
Malignant melanoma arising de novo Malignant Melanoma of Conjunctiva
3­4 Poorly differentiated/ undifferentiated (marked anaplasia) (Gleason 7– 10) Prostata
Poorly differentiated/ undifferentiated Penis, Kidney, Renal Pelvis and Ureter, Urinary Bladder, Urethra
4 undifferentiated Undifferenziert all but Prostata, Penis, Kidney, Renal Pelvis and Ureter, Urinary Bladder, Urethra, Malignant Melanoma of Conjunctiva
9 Grading not performed, not given or not applicable
L low malignity (G1­G2) Niedriggradig maligne (G1­G2)
M intermediate malignity (G2­G3) Mittelgradig maligne (G2­G3)
H high malignity (G3­G4) Hochgradig maligne (G3G4)
B Borderline Grenzfall
X grade of differentiation cannot be assessed Differenzierungs­grad nicht be­stimmbar
This Grading may either be a qualifier in a containing ICDO or be documented as a component in a stand-alone code.

Table 16:Grade of Differentiation/Gradings (OID 1.2.276.0.76.5.336) 14 DIMDI www.dimdi.de ICD-O-3


Cell Type

This qualifier identifies the immune phenotype related to a lymphoma.

Code Meaning Explanation  
T T­ cell type affects T ­lymphocytes
B B­ cell type affects B lymphocytes
N   Null cell type NHL  Th0, null cell type lymphoma (and T-cell)
K Natural­ Killer cell type   affects NK­ cells: rare lymphoma, mostly in nose or of nasal type
X not determineable (undifferentiated lymphoma)
9 affected cell type determination not performed, not specified or not applicable
U unknown, nullFlavor=UNK

Table 17: Lymphoma-Affected Cell Type (OID 1.2.276.0.76.5.???)

Validity of R Classification

This qualifier documents the focus of the Residual¬ Classification15.

Code Meaning Explanation  
L locoregionary tumor nearby tumor(s)
M distant metastasis distant secondary tumors
G overall phenomenon

Table 18: Validity of R-Classifikation (OID 1.2.276.0.76.5.???) 15 Altmann based on TNM V7, Giessen, 2010

Existence of Residual Tumor

This qualifier indicates, where a Residual Tumor exists ref. 16.

Code Meaning Explanation
L locoregionary tumor nearby tumor(s)
F distant metastasis distant secondary tumors
B both
U unknown nullFlavor=UNK

Existence of residual Tumor

16 Dudeck J. Basisdokumentation für Tumorerkrankte. Giessen. 1999.

Codes for TNM-Classification

Information icon.svg The TNM classification according to UICC is being a codesystem as a whole. Therefore all tables share the same OID for documentation purposes.

An easy way to handle this is the definition of value sets, each with the respective permitted values.

Each code may only be used in some documentation if the respective UICC edition is checkmarked in our table– which states that the respective code is a part of that edition.

Tumors

This section lists known T-Categories ref. 17 (without representing possible extensions). Descriptions vary with the related entity. Codes shall be used along with tumor diagnosis, as one code may have different meanings. (e.g. T1 may refer to 23 cm or 24 cm).

Code Description Explanation 5. 6. 7.
Ta X X X
Tis Carcinoma in situ non invasive X X X
T0 No evidence of primary tumour X X
T1 X X X
T1mic micro invasion X X X
T1a X X X
T1a1 X X X
T1a2 X X X
T1b X X X
T1b1 X X X
T1b2 X X X
T1c X X X
T1d X
T2 X X X
T2a X X X
T2a1 X
T2a2 X
T2b X X X
T2c X X X
T2d X
T3 X X X
T3a X X X
T3b X X X
T3c X X X
T3d X X
T4 X X X
T4a X X X
T4b X X X
T4c X X X
T4d X X X
T4e X
TX Primary tumor cannot be assessed Stage of primary tumor cannot be determined

Table 20: (T) Tumor Codes Value Set (OID 1.2.276.0.76.11.1) 17 TNM 5.,6.,7. Edition

Nodes

Any code for involvement of lymph nodes shall only be used together with tumor diagnosis.

UICC UICC UICC
Code Description Meaning Entity 5. 6. 7.
N0 No regional lymph node metastasis no lymph node affected all X X X
N1 X X X
N1mi Bilateral regional lymph node metastasis vulva X X
N1a all X X X
N1b X X X
N1b1 X
N1b2 X
N1b3 X
N1b4 X
N1c X X
N2 X X X

Table 21: (N) Lymph Node Codes Value Set (OID 1.2.276.0.76.11.2)

Metastasis

Code describing distant metastases shall only be used together with tumor diagnosis.

Code Description German Entity 5. 6. 7.
UICC UICC UICC
M0 No distant metastasis Fernmetastasen nicht vorhanden all X X X
M1 Distant metastasis Fernmetastasen vorhanden all X X X
M1a only oesophagus / prostate X X X
M1b only oesophagus / prostate X X X
M1c X X X
M1d X
M1e X
MX Distant metastasis cannot be assessed all X X X

Table 22: (M) Metastasis Code Value Set (OID 1.2.276.0.76.11.3)

Residual Tumor

Code Description German
R0 No residual tumour kein Residualtumor
R1 Microscopic residual tumour nur mikroskopisch Residualtumor nachweisbar
R2 Macroscopic residual tumour and makroskopischer Residualtumor und
R2a microscopically not confirmed ­mikroskopisch nicht bestätigt
R2b microscopically confirmed ­mikroskopisch bestätigt
RX Presence of residual tumour cannot be assessed Unbekannt

Table 23: Residualtumor Codes Value Set (OID 1.2.276.0.76.11.4)

Stage grading as of UICC

Code Description Meaning 5. 6. 7.
UICC
okk TX, N0, M0 X X X
0 Carcinoma in situ Tis, N0, M0 X X X
0a X X X
0is X X X
I X X
IA T1, N0, M0 X X X
IA1 X X X
IA2 X X X
IB T2, N0, M0 X X X
IB1 X X X
IB2 X X X
IC X X X
II X X X
IIA T1, N1, M0 X X X
IIA1 X
IIA2 X
IIB T2, N1, M0 X X X
IIC T3, N0, M0 X X X
III X X X
IIIA T1, N2, M0 X X X
IIIA T2, N2, M0
IIIA T3, N1,2, M0
IIIB T4, each N, M0 X X X
IIIB each T, N3, M0
IIIC X X X
IS X X X
IV each T, each N, M1 X X X
IVA X X X
IVB X X X
IVC X X X
not defined X X X
not recommended X X

Table 24: Stage Classification ref. 18 Value Set (OID 1.2.276.0.76.11.5)

18 In: Schmoll HJ, Höffken K, Possinger K eds. Kompendium Internistische Onkologie. „Collection of Internistic Oncology “. Springer. 4. Edition; 2006

Venous Invasion

Code Description German
V0 no venous invasion keine Veneninvasion
V1 microscopic venous invasion mikroskopische Veneninvasion
V2 macroscopic venous invasion makroskopische Veneninvasion
VX venous invasion cannot be assessed Veneninvasion nicht feststellbar

Table 25: Venous Invasion Code Value Set (OID 1.2.276.0.76.11.6)

Lymphatic System Invasion

Code Description German
L0 no lymphatic invasion keine Lymphsysteminvasion
L1 lymphatic invasion Lymphsysteminvasion
LX lmphatic invasion cannot be assessed Lymphsysteminvasion nicht fest­stellbar

Table 26: Lymphatic Invasion Codes Value Set (OID 1.2.276.0.76.11.7)

Perineural Invasion

Code Description German
Pn0 no perineural invasion keine perineurale Invasion
Pn1 Perineural invasion perineurale Invasion
PnX unknown Unbekannt

Table 27: Perineural Invasion Code Value Set (OID 1.2.276.0.76.11.8)

Qualifier

Code Description German
c Assessment according to clinical criteria Beurteilung nach klinischen Kriterien
p according to the pathological results nach dem pathologischen Befund
r TNM result of recurrent tumor TNM­Befund für Rezidivtumor
y Classification of initial multimodal therapy Klassifikation nach initialer multi­modaler Therapie

Table 28: TNM-Qualifier Value Set (OID 1.2.276.0.76.11.9)

Certainty

Code Description of Evidence German
C1 Evidence from standard diagnostic means (e.g., inspection, palpation, and standard radiography, intraluminal endoscopy for tumours of certain organs) Nachweis durch diagnostische Standardmethoden (Inspektion, Palpation, einfache Röntgenaufnahmen)
C2 Evidence obtained by special diagnostic means (e.g., radiographic imaging in special projections, tomography, computerized tomography [CT], ultrasonography, lymphography, angiography,scintigraphy,magnetic resonance imaging [MRI],endoscopy, biopsy, and cytology) Nachweis durch spezielle klinische diagnostische Methoden einschließlich Computertomogramm, Magnet­Resonanz­Tomographie
C3 Evidence from surgical exploration, including biopsy and cytology Nachweis durch Operation, einschließlich Biopsie und Zytologie
C4 Evidence of the extent of disease following definitive surgery and pathological examination of the resected specimen Nachweis durch operative Behandlung mit pathologischer Untersuchung der entnommenen Gewebeteile
C5 Evidence from autopsy Nachweis durch Autopsie

Table 29: Certainty Factor Codes (OID 1.2.276.0.76.5.341)

Localisation of Distant Tumours / Metastases

Code Description German Explanation
PUL Pulmonary Pulmonal Lungenmetastase
OSS Osseous Ossär Knochenmetastase
HEP Hepatic Hepatisch Lebermetastase
BRA Brain Cerebral Hirnmetastase
LYM Lymph Nodes Lymphonodulär Lymphknotenmetastase
OTH Others Andere Andere Metastase
MAR Bone Marrow Medullär Knochenmarkmetastase
PLE Pleura Pleural RippenfellMetastase
ADR Adrenals Adrenal Nebennierenmetastase
SKI Skin dermal Hautmetastase

Table 30: Metastases Localisation Codes (OID 1.2.276.0.76.5.401)

Codes for Gleason Score

The Gleason Grading system helps evaluating the prognosis of men with prostate cancer, as a part of a strategy of prostate cancer staging which predicts prognosis and guides therapy. The Gleason score is based on microscopic findings.

Code Description German
1 Round to oval equal individual glands, lying close to each other, sharply demarcated from the surrounding area Runde bis ovale gleich große Einzeldrüsen, dicht nebeneinander liegend, scharf gegen die Umgebung abgegrenzt
2 Slightly less uniform single glands, separated by small amounts of stroma, less sharply defined tumor margin Etwas weniger uniforme Einzeldrüsen, getrennt durch geringe Mengen von Stroma, weniger scharf begrenzter Tumorrand
3 a) Irregularly large and irregularly shaped glands, usually with abundant stroma, sometimes also stored tightly irregular and indistinct tumor border Unregelmäßig große und unregelmäßig gestaltete Drüsen mit gewöhnlich reichlicherem Stroma, gelegentlich auch dicht gelagert, unregelmäßige und unscharfe Tumorgrenze
b) Papillary or cribriform structures, sometimes in large gang­like formations Papilläre oder kribriforme Strukturen, z.T. in großen gangähnlichen Bildungen
4 "a) Large irregular epithel formations by glandular fusion (""fused glands"") and branched glands with irregular infiltration into the surrounding area " Große unregelmäßige Epithelformationen durch Drüsenverschmelzung („fused glands“) sowie verzweigte Drüsen mit unregelmäßiger Infiltration in die Umgebung
b) Adenocarcinoma with prominent clear cytoplasm similar to clear cell adenocarcinomas of the kidney Adenokarzinom mit ausgeprägt klarem Zytoplasma ähnlich hellzelligen Adenokarzinomen der Niere
5 a) Circumscribed round epithelial clusters with mostly solid and cribriform construction, usually with central necrosis Scharf begrenzte runde Epithelhaufen mit meist solidem und kribriformem Bau, gewöhnlich mit zentraler Nekrose
(comedo carcinoma­like) (komedo­karzinomähnlich)
b) Irregularly shaped formations of an undifferentiated carcinoma, which only just discernible glandular formation or is identified vacuoles (signet ring­like) than adenocarcinoma Unregelmäßig begrenzte Formationen eines undifferenzierten Karzinoms, das nur durch gerade noch erkennbare Drüsenbildung oder Vakuolen (siegelringähnlich) als Adenokarzinom zu identifizieren ist

Table 31: Loss of Differentiation according to Gleason Score ref. 19 (OID 1.2.276.0.76.5.402)

Documentation by the GleasonSum (Gleason¬Score) as the sum of the two most dominating findings: Uniformly structured tumors: two times the points of above table. Non-uniformly structured tumors: points for the dominating share of findings (so-called primary grading) + points for second-largest share (secondary grading), if punch biopsy show more than two grades, the second component will be based on the most adverse component found.

19: Dt. Gesellschaft f. Urologie e.V.

Ann Arbor Codes

The tumor staging system for lymphomas.

Principal Stages

Code Description
I cancer is located in a single region, usually one lymph node and the surrounding area
II cancer is located in two separate regions, an affected lymph node or organ and a second affected area, and that both affected areas are confined to one side of the diaphragm
III cancer has spread to both sides of the diaphragm, including one organ or area near the lymph nodes or the spleen
IV diffuse or disseminated involvement of one or more extralymphatic organs

Table 33: Ann Arbor (OID 1.2.276.0.76.5.405)

Modifiers for Constitutional Symptoms

Code Description
A absence of constitutional symptoms is denoted by adding an ""A""
B presence of constitutional (B-type) symptoms is denoted by adding a ""B""

Table 34: Ann Arbor constitutional symptoms (OID 1.2.276.0.76.5.416 Attention icon.svg Falsche OID: 1.2.276.0.76.5.416 ist atcgm2013))

Modifiers for Spread of Tumor

Code Description
E disease is ""extranodal"" (not in the lymph nodes) or has spread from lymph nodes to adjacent tissue.
S the disease has spread to the spleen.
X the largest deposit is >10 cm large (""bulky disease""), or the mediastinum is wider than 1/3 of the chest on a chest X-ray.

Table 35: Ann Arbor Extensions for Spreading in Organs Code Set (OID 1.2.276.0.76.5.417) Attention icon.svg Falsche OID: 1.2.276.0.76.5.417 ist icd10gm2014

Papanicolaou Coding

Results of the so-called Pap-Test

Code Meaning
Pap0 non representative sample
PapI normal cell findings
PapII atypical, benign disorder, infection, metaplasia, atrrophy, bacteria, viruses,
PapIIw insufficient samples
PapIII cell proliferation and atypic cells
PapIIID dysplastic , mostly with HPV infection
PapIIIG moderate/severe dyskaryosis and/or dysplasia
PapIV biopsy sample and histological clarification required
PapIVa carcinoma in situ
PapIVb single certain tumour cells, carcinoma very certain
PapV many certain tumour cells, carcinoma certain, cellular changes suggestive of invasive squamous carcinoma, and cellular changes indicative of adenocarcinoma of the uterine cervix and other invasive cancer.

Table 36: Grading according to Papanicolaou (OID 1.2.276.0.76.5.406)

Abgerufen von „https://wiki.hl7.de/index.php?title=IG:HL7_diagnosis&oldid=20754“